Michelle D. Williams, M.D.

Peer-Reviewed Articles

1. Maniakas, A, Wilde, DC, Fournier, I, Hyde, EK, Xu, L, Wang, RJ, Gross, N, Sturgis, EM, Banuchi, VE, Busaidy, NL, Cabanillas, ME, Iyer, PC, Dadu, R, Waguespack, SG, Hu, MI, Gunn, GB, Kwon, M, Ahmed, S, Williams, MD, Zafereo, M. Segmental Tracheal Resection for Thyroid Cancer. Head and Neck 48(3):644-649, 2026. e-Pub 2026. PMID: 41059669.
2. Fournier, I, Bandi, A, Hamidi, S, Iyer, PC, Busaidy, NL, Cabanillas, ME, Dadu, R, Hu, MI, Waguespack, SG, Basmaci, UN, Williams, MD, Mansour, M, Monroe, MG, Gross, N, Goepfert, RP, Perrier, ND, Banuchi, VE, Wang, RJ, Maniakas, A, Zafereo, M. Management of Retropharyngeal Lymph Node Metastases in Thyroid Cancer. Head and Neck 48(1):237-245, 2026. e-Pub 2026. PMID: 40891104.
3. Moreno, AC, Sahli, A, Johnson, FM, Sun, X, Barbon, CE, Rinsurongkawong, W, Song, W, Luciani, FM, Liang, H, Li, J, Liu, W, Lee, JJ, Frank, SJ, Lai, SY, Fuller, C, Hutcheson, KA, Fuller, C, Lee, J, Frank, S, Mohamed, AS, Peterson, CB, McMillan, H, Ma, J, Brock, K, Wang, L, Chambers, MS, Williams, MD, Naser, M, He, R, Shete, S, Zhang, X, Whinsenant, M. Stiefel MD Anderson OroPharynx cancer (MDA-OPC) cohort. BMJ open 15(11), 2025. e-Pub 2025. PMID: 41290309.
4. Jiang, XL, Rudqvist, N, Jiang, B, Ye, S, He, S, Liang, Q, Dou, J, Williams, MD, Dunn, J, Johnson, JM, Akagi, K, Xiao, W, Liang, S, Elayavalli, S, Sun, B, Parra Cuentas, ER, Ferrarotto, R, Garden, AS, Fuller, C, Reddy, JP, Gross, N, Lango, MN, Leung, CH, Liu, S, Liu, D, Li, M, Lee, JJ, Curran, M, Phan, J, Chen, K, Gillison, M. Depletion of Effector Regulatory T Cells Associates with Major Response to Induction Dual Immune Checkpoint Blockade. Cancer discovery 15(8):1569-1592, 2025. e-Pub 2025. PMID: 40249124.
5. Cabanillas, ME, Busaidy, NL, Gunn, GB, Iyer, PC, Ferrarotto, R, Gule-Monroe, MK, Maniakas, A, Williams, MD, Liu, S, Fellman, B, Spiotto, MT, Hamidi, S, Akhave, NS, Lee, A, Wang, RJ, De Sousa, LG, Marczyk, VR, Zafereo, M, Dadu, R. Adjuvant Pembrolizumab after Upfront Multimodal Therapy for Stage IVB Anaplastic Thyroid Cancer. Thyroid 35(7):763-770, 2025. e-Pub 2025. PMID: 40609521.
6. Salem, AF, Chen, MM, Williams, MD, Swanson, DM, McQuade, JL, Amaria, RN, Hanna, EY, Bishop, AJ, Farooqi, AS, Guadagnolo, BA, Su, SY, Mitra, D. Resectable Sinonasal Mucosal Melanoma in the Immunotherapy Era. Head and Neck 47(7):1848-1856, 2025. e-Pub 2025. PMID: 39906003.
7. Hamidi, S, Dadu, R, Iyer, PC, Busaidy, NL, Maniakas, A, Wang, RJ, Banuchi, VE, Hosseini, SM, Williams, MD, Zafereo, M, Cabanillas, ME. Circulating Tumor DNA as a Biomarker for Disease Surveillance in Anaplastic Thyroid Cancer. JCO Precision Oncology 9, 2025. e-Pub 2025. PMID: 40570261.
8. Cabanillas, ME, Akhave, NS, Banuchi, VE, Busaidy, NL, Dadu, R, Ferrarotto, R, Gunn, GB, Hamidi, S, Hofmann, M, Hosseini, SM, Iyer, PC, Lai, SY, Lee, A, Maniakas, A, Ning, M, Spiotto, MT, Wang, RJ, Williams, MD, Zafereo, M. Reimagining the Therapeutic Approach for Anaplastic Thyroid Cancer. Thyroid 35(5):462-470, 2025. e-Pub 2025. PMID: 40388579.
9. Marczyk, VR, Fazeli, S, Dadu, R, Busaidy, NL, Iyer, PC, Hu, MI, Sherman, SI, Hamidi, S, Hosseini, SM, Williams, MD, Ahmed, S, Routbort, MJ, Luthra, R, Roy Chowdhuri, S, San Lucas, FA, Patel, KP, Hong, DS, Zafereo, M, Wang, RJ, Maniakas, A, Waguespack, SG, Cabanillas, ME. NTRK Fusion-Positive Thyroid Carcinoma. JCO Precision Oncology 9, 2025. e-Pub 2025. PMID: 39983078.
10. Contrera KJ, Ferrarotto R, Gunn B, Su SY, Kies MS, Glisson BS, Garden AS, Roberts D, Hanba C, Hoff CO, El-Naggar A, Williams MD, Raza SM, DeMonte F, Chen MM, Chambers MS, Hanna EY. Phase II Trial of Induction Chemotherapy for Advanced Sinonasal Squamous Cell Carcinoma. Clin Cancer Res 31(2):258-265, 2025. e-Pub 2025. PMID: 39531535.
11. Eldaya, R, Kaya, D, Williams, MD, Calle, S, Schellingerhout, D. Clinical and Imaging Features of Head and Neck Metastasis of High-Grade Glioma. American Journal of Neuroradiology 46(1):160-165, 2025. e-Pub 2025. PMID: 39667825.
12. Jin L, Tang Y, Coole JB, Tan MT, Zhao X, Badaoui H, Robinson JT, Williams MD, Vigneswaran N, Gillenwater AM, Richards-Kortum RR, Veeraraghavan A. DeepDOF-SE: affordable deep-learning microscopy platform for slide-free histology. Nat Commun 15(1), 2024. e-Pub 2024. PMID: 38580633.
13. Rodrigues VM, Fazeli S, Waguespack SG, Dadu R, Busaidy NL, Iyer P, Hu MI, Sherman SI, Hamidi S, Hosseini SM, Elzamly S, Williams MD, Ahmed S, Routbort MJ, Luthra R, Patel KP, Zafereo M, Wang JR, Maniakas A, Cabanillas ME. NTRK Fusion-Positive Thyroid Carcinoma: From Diagnosis to Targeted Therapy. JCO Precision Oncology. e-Pub 2024.
14. Cabanillas ME, Dadu R, Ferrarotto R, Gule-Monroe M, Liu S, Fellman B, Williams MD, Zafereo M, Wang JR, Lu C, Ning M, McKinley BA, Woodman SE, Duose D, Gunn GB, Busaidy NL. Anti-Programmed Death Ligand 1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma: A Nonrandomized Clinical Trial. JAMA Oncol 10(12):1672-1680, 2024. e-Pub 2024. PMID: 39446377.
15. Zhao J, Williams MD, Hernandez M, Kuang G, Goldberg H, Fan J, Ning J, Ferrarotto R, Esmaeli B. Prognostic Impact of Notch1 Intracellular Domain, P63, and c-MYC in Lacrimal Gland Adenoid Cystic Carcinoma. Invest Ophthalmol Vis Sci 65(11):4, 2024. e-Pub 2024. PMID: 39230995.
16. Feldman HA, Busaidy NL, Tame-Elorduy A, Silva AK, Halfteck G, Merriman K, Waguespack SG, Graham PH, Williams MD, Perrier ND. Clinical course of atypical parathyroid neoplasm with soft tissue extension. J Surg Oncol 130(5):1092-1096, 2024. e-Pub 2024. PMID: 39155668.
17. Wang JR, Zafereo ME, Cabanillas ME, Wu CC, Xu L, Dai Y, Wang W, Lai SY, Henderson Y, Erasmus L, Williams MD, Joshu C, Ray D. The Association Between Thyroid Differentiation Score and Survival Outcomes in Papillary Thyroid Carcinoma. J Clin Endocrinol Metab 110(2):356-363, 2024. e-Pub 2024. PMID: 39087944.
18. Islam S, Gleber-Netto FO, Mulcahy CF, Glaun MDE, Srivastava S, Hunt PJ, Williams MD, Barbon CE, Spiotto M, Zhao W, Adebayo A, Akhter S, Xie T, Debnath KC, Sathishkumar HN, Myers B, Lothumalla S, Yaman I, Burks JK, Gomez J, Rao X, Wang J, Woodman K, Mansour J, Arenkiel B, Osman KL, Haxton C, Lever TE, Hutcheson KA, Amit M. Neural landscape is associated with functional outcomes in irradiated patients with oropharyngeal squamous cell carcinoma. Sci Transl Med 16(758):eabq5585, 2024. e-Pub 2024. PMID: 39083586.
19. Hamidi S, Dadu R, Zafereo ME, Ferrarotto R, Wang JR, Maniakas A, Gunn GB, Lee A, Spiotto MT, Iyer PC, Sousa LG, Akhave NS, Ahmed S, Learned KO, Lu C, Lai SY, Williams M, Hosseini SM, Busaidy NL, Cabanillas ME. Initial Management of BRAF V600E-Variant Anaplastic Thyroid Cancer: The FAST Multidisciplinary Group Consensus Statement. JAMA Oncol 10(9):1264-1271, 2024. e-Pub 2024. PMID: 38990526.
20. Goldberg H, Jiang X, Fan J, Zhao J, Ning J, Williams MD, Frank S, Moreno A, Gunn B, Ferrarotto R, Esmaeli B. Lacrimal Gland Adenocarcinoma Clinicopathologic Features and Outcomes Compared With Those of Lacrimal Gland Adenoid Cystic Carcinoma. Ophthalmic Plast Reconstr Surg 40(4):419-425, 2024. e-Pub 2024. PMID: 38319188.
21. Williams MD, Liu Z, Rossi ED, Agarwal S, Ryska A, Ghuzlan AA, Bychkov A, Baloch Z, Chernock R, Chiosea SL, Cipriani NA, Erkilic S, Fridman M, Hang JF, Harahap AS, Jung CK, Kakudo K, Khalil M, Khanafshar E, Kumarasinghe P, Lloyd R, Nguyen TP, Ocal IT, Prasad ML, Pusztaszeri M, Rana C, Sadow P, Sajed DP, Seethala R, Tallini G, Vuong HG, Yegen G, LiVolsi VA, Nikiforov YE. Seven years of Non-invasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features (NIFTP): Rate of Acceptance and Variation of Diagnostic Approaches Across Different Continents. J Clin Endocrinol Metab 110(1):166-175, 2024. e-Pub 2024. PMID: 38874075.
22. Zeng PYF, Prokopec SD, Lai SY, Pinto N, Chan-Seng-Yue MA, Clifton-Bligh R, Williams MD, Howlett CJ, Plantinga P, Cecchini MJ, Lam AK, Siddiqui I, Wang J, Sun RX, Watson JD, Korah R, Carling T, Agrawal N, Cipriani N, Ball D, Nelkin B, Rooper LM, Bishop JA, Garnis C, Berean K, Nicolson NG, Weinberger P, Henderson YC, Lalansingh CM, Tian M, Yamaguchi TN, Livingstone J, Salcedo A, Patel K, Vizeacoumar F, Datti A, Xi L, Nikiforov YE, Smallridge R, Copland JA, Marlow LA, Hyrcza MD, Delbridge L, Sidhu S, Sywak M, Robinson B, Fung K, Ghasemi F, Kwan K, MacNeil SD, Mendez A, Palma DA, Khan MI, Shaikh M, Ruicci KM, Wehrli B, Winquist E, Yoo J, Mymryk JS, Rocco JW, Wheeler D, Scherer S, Giordano TJ, Barrett JW, Faquin WC, Gill AJ, Clayman G, Boutros PC, Nichols AC. The genomic and evolutionary landscapes of anaplastic thyroid carcinoma. Cell Rep 43(3):113826, 2024. e-Pub 2024. PMID: 38412093.
23. Maniakas A, Sullivan A, Hu MI, Busaidy NL, Cabanillas ME, Dadu R, Waguespack SG, Fisher SB, Graham PH, Gross ND, Grubbs EG, Perrier ND, Wang JR, Gunn B, Garden AS, Megahed R, Navuluri S, Li X, Williams MD, Zafereo M. Decreasing utilization for postoperative radiation therapy in locoregionally advanced medullary thyroid cancer. Head and Neck 46(2):328-335, 2024. e-Pub 2024. PMID: 38009416.
24. de Sousa, LG, Siqueira, JM, McGrail, DJ, Marques-Piubelli, ML, Neto, FL, Borgogno, SF, Nunes, FD, De Matos, LL, Kowalski, LP, Hoff, CO, Dai, H, Mitani, Y, Li, K, Williams, MD, Lin, S, El-Naggar, AK, Sikora, AG, Burks, JK, Gillison, M, Ferrarotto, R. The immunological milieu of oropharyngeal squamous cell carcinoma (OPC) according to HPV and smoking status and its influence on prognosis. Journal of Clinical Oncology 42(16), 2024. e-Pub 2024.
25. Na’ara, S, Yaniv, D, Andrews, C, Sathishkumar, HN, Guimaraes de Sousa, L, Akhave, NS, Williams, MD, Myers, JN, Chambers, MS, Amit, M. Intralesional nivolumab in oral potentially malignant disorders. Journal of Clinical Oncology 42(16_suppl):6016, 2024. e-Pub 2024.
26. Szabo Yamashita T, Shirali AS, Meas S, Sarli V, Clemente-Gutierrez UE, Chiang YJ, Silva-Figueroa A, Vodopivec DM, Williams MD, Fisher SB, Graham PH, Grubbs EG, Lucci A, Busaidy N, Perrier ND. Is there a role for liquid biopsy in the surveillance of parathyroid carcinoma?. Surgery 175(1):193-198, 2024. e-Pub 2024. PMID: 37993289.
27. Iyer P, Dadu R, Ferrarotto R, Busaidy NL, Habra MA, Hess KR, Gule-Monroe M, Williams MD, Cabanillas ME. Molecular Targeted Therapy for the Treatment of Anaplastic Thyroid Carcinoma. Thyroid, 2024.
28. Valenciaga A, Grubbs EE, Porter K, Wakely PE, Williams MD, Cote GJ, Vasko VV, Saj M, Ringel MD. Reduced Retinoblastoma Protein Expression is Associated With Decreased Patient Survival in Medullary Thyroid Cancer. Thyroid, 2024. e-Pub 2024. PMID: 29105562.
29. Contrera KJ, Shakibai N, Su SY, Gule-Monroe MK, Roberts D, Brahimaj B, Williams MD, Ferrarotto R, Phan J, Gunn B, Raza S, DeMonte F, Hanna EY. Impact of Clinical Factors and Treatments on SMARCB1 (INI-1)-Deficient Sinonasal Carcinoma. Otolaryngol Head Neck Surg 169(2):435-440, 2023. e-Pub 2023. PMID: 36856048.
30. Lu L, Wang JR, Henderson YC, Bai S, Yang J, Hu M, Shiau CK, Pan T, Yan Y, Tran TM, Li J, Kieser R, Zhao X, Wang J, Nurieva R, Williams MD, Cabanillas ME, Dadu R, Busaidy NL, Zafereo M, Navin N, Lai SY, Gao R. Anaplastic transformation in thyroid cancer revealed by single-cell transcriptomics. J Clin Invest 133(11), 2023. e-Pub 2023. PMID: 37053016.
31. Zhao X, Wang JR, Dadu R, Busaidy NL, Xu L, Learned KO, Chasen NN, Vu T, Maniakas A, Eguia AA, Diersing J, Gross ND, Goepfert R, Lai SY, Hofmann MC, Ferrarotto R, Lu C, Gunn GB, Spiotto MT, Subbiah V, Williams MD, Cabanillas ME, Zafereo ME. Surgery After BRAF-Directed Therapy Is Associated with Improved Survival in BRAF(V600E) Mutant Anaplastic Thyroid Cancer: A Single-Center Retrospective Cohort Study. Thyroid 33(4):484-491, 2023. e-Pub 2023. PMID: 36762947.
32. Chen YH, Cabanillas M, Sperling J, Xu L, Goswami M, Maniakas A, Williams MD, Lai SY, Busaidy N, Dadu R, Zafereo ME, Wang JR. Prior Thyroid and Nonthyroid Cancer History Do Not Significantly Alter Overall Survival in Patients Diagnosed with Anaplastic Thyroid Cancer. Thyroid 33(3):321-329, 2023. e-Pub 2023. PMID: 36511380.
33. Coole JB, Brenes D, Mitbander R, Vohra I, Hou H, Kortum A, Tang Y, Maker Y, Schwarz RA, Carns J, Badaoui H, Williams M, Vigneswaran N, Gillenwater A, Richards-Kortum R. Multimodal optical imaging with real-time projection of cancer risk and biopsy guidance maps for early oral cancer diagnosis and treatment. J Biomed Opt 28(1):016002, 2023. e-Pub 2023. PMID: 36654656.
34. Contrera KJ, Gule-Monroe MK, Hu MI, Cabanillas ME, Busaidy NL, Dadu R, Waguespack SG, Wang JR, Maniakas A, Lai SY, Diersing J, Kwon M, Grubbs EG, Subbiah V, Williams MD, Zafereo ME. Neoadjuvant Selective RET Inhibitor for Medullary Thyroid Cancer: A Case Series. Thyroid 33(1):129-132, 2023. e-Pub 2023. PMID: 36503246.
35. Zhang X, Gleber-Netto FO, Wang S, Martins-Chaves RR, Gomez RS, Vigneswaran N, Sarkar A, William WN, Papadimitrakopoulou V, Williams MD, Bell D, Palsgrove D, Bishop J, Heymach JV, Gillenwater AM, Myers JN, Ferrarotto R, Lippman SM, Pickering CR, Xiao G. Deep learning-based pathology image analysis predicts cancer progression risk in patients with oral leukoplakia. Cancer Med. e-Pub 2023. PMID: 36721313.
36. Brenes DR, Nipper AJ, Tan MT, Gleber-Netto FO, Schwarz RA, Pickering CR, Williams MD, Vigneswaran N, Gillenwater AM, Sikora AG, Richards-Kortum RR. Mildly dysplastic oral lesions with optically-detectable abnormalities share genetic similarities with severely dysplastic lesions. Oral Oncol 135:106232, 2022. e-Pub 2022. PMID: 36335817.
37. Ho J, Mattei J, Tetzlaff M, Williams MD, Davies MA, Diab A, Oliva ICG, McQuade J, Patel SP, Tawbi H, Wong MK, Fisher SB, Hanna E, Keung EZ, Ross M, Weiser R, Su SY, Frumovitz M, Meyer LA, Jazaeri A, Pettaway CA, Guadagnolo BA, Bishop AJ, Mitra D, Farooqi A, Bassett R, Faria S, Nagarajan P, Amaria RN. Neoadjuvant checkpoint inhibitor immunotherapy for resectable mucosal melanoma. Front Oncol 12:1001150, 2022. e-Pub 2022. PMID: 36324592.
38. Zhao J, Papp AM, Williams MD, Debnam JM, Esmaeli B. Multifocal recurrence of pleomorphic adenoma of the lacrimal gland. Am J Ophthalmol Case Rep 27:101600, 2022. e-Pub 2022. PMID: 35677816.
39. Contrera KJ, Huang AT, Shenson JA, Tang C, Roberts D, Myers JN, Weber RS, Lai SY, Williams M, El-Hallal M, Jacob D, Zafereo M. Primary and recurrent regional metastases for lateralized oral cavity squamous cell carcinoma. Surg Oncol 44:101804, 2022. e-Pub 2022. PMID: 35932620.
40. Sajisevi M, Caulley L, Eskander A, Du YJ, Auh E, Karabachev A, Callas P, Conradie W, Martin L, Pasternak J, Golbon B, Rolighed L, Abdelhamid Ahmed AH, Badhey A, Cheung AY, Corsten M, Forner D, Liu JC, Mavedatnia D, Meltzer C, Noel JE, Patel V, Sharma A, Tang AL, Tsao G, Venkatramani M, Williams M, Wrenn SM, Zafereo M, Stack BC Jr, Randolph GW, Davies L. Evaluating the Rising Incidence of Thyroid Cancer and Thyroid Nodule Detection Modes: A Multinational, Multi-institutional Analysis. JAMA Otolaryngol Head Neck Surg 148(9):811-818, 2022. e-Pub 2022. PMID: 35834240.
41. Wang JR, Montierth M, Xu L, Goswami M, Zhao X, Cote G, Wang W, Iyer P, Dadu R, Busaidy NL, Lai SY, Gross ND, Ferrarotto R, Lu C, Gunn GB, Williams MD, Routbort M, Zafereo ME, Cabanillas ME. Impact of Somatic Mutations on Survival Outcomes in Patients With Anaplastic Thyroid Carcinoma. JCO Precis Oncol 6:e2100504, 2022. e-Pub 2022. PMID: 35977347.
42. Boucai L, Seshan V, Williams MD, Knauf JA, Saqcena M, Ghossein RA, Fagin JA. Characterization of Subtypes of BRAF-Mutant Papillary Thyroid Cancer Defined by Their Thyroid Differentiation Score. J Clin Endocrinol Metab 107(4):1030-1039, 2022. e-Pub 2022. PMID: 34897468.
43. Caulley L, Eskander A, Yang W, Auh E, Cairncross L, Cho NL, Golbon B, Iyer S, Liu JC, Lee PJ, Lindeman B, Meltzer C, Molin N, Moore A, Noel J, Nozolino H, Pasternak J, Price B, Ramsay T, Rolighed L, Sajisevi M, Sharma A, Sinclair C, Sorensen M, Tae K, Tang AL, Tsao G, Williams M, Wrenn S, Xing MH, Zafereo M, Stack BC, Randolph G, Davies L. Trends in Diagnosis of Noninvasive Follicular Thyroid Neoplasm With Papillarylike Nuclear Features and Total Thyroidectomies for Patients With Papillary Thyroid Neoplasms. JAMA Otolaryngol Head Neck Surg 148(2):99-106, 2022. e-Pub 2022. PMID: 34817546.
44. Liu Z, Williams MD, Stewart J, Glisson BS, Fuller C, Roy-Chowdhuri S. Evaluation of programmed death ligand 1 expression in cytology to determine eligibility for immune checkpoint inhibitor therapy in patients with head and neck squamous cell carcinoma. Cancer Cytopathol 130(2):110-119, 2022. e-Pub 2021. PMID: 34375025.
45. Maniakas A, Henderson YC, Hei H, Peng S, Chen Y, Jiang Y, Ji S, Cardenas M, Chiu Y, Bell D, Williams MD, Hofmann MC, Scherer SE, Wheeler DA, Busaidy NL, Dadu R, Wang JR, Cabanillas ME, Zafereo M, Johnson FM, Lai SY. Novel Anaplastic Thyroid Cancer PDXs and Cell Lines: Expanding Preclinical Models of Genetic Diversity. J Clin Endocrinol Metab 106(11):e4652-e4665, 2021. e-Pub 2021. PMID: 34147031.
46. Bagheri-Yarmand R, Busaidy NL, McBeath E, Danysh BP, Evans KW, Moss TJ, Akcakanat A, Ng PKS, Knippler CM, Golden JA, Williams MD, Multani AS, Cabanillas ME, Shaw KR, Meric-Bernstam F, Shah MH, Ringel MD, Hofmann MC. RAC1 Alterations Induce Acquired Dabrafenib Resistance in Association with Anaplastic Transformation in a Papillary Thyroid Cancer Patient. Cancers (Basel) 13(19), 2021. e-Pub 2021. PMID: 34638434.
47. Henderson YC, Mohamed ASR, Maniakas A, Chen Y, Powell RT, Peng S, Cardenas M, Williams MD, Bell D, Zafereo ME, Wang RJ, Scherer SE, Wheeler DA, Cabanillas ME, Hofmann MC, Johnson FM, Stephan CC, Sandulache V, Lai SY. A High-throughput Approach to Identify Effective Systemic Agents for the Treatment of Anaplastic Thyroid Carcinoma. J Clin Endocrinol Metab 106(10):2962-2978, 2021. e-Pub 2021. PMID: 34120183.
48. Qin Y, Wang JR, Wang Y, Iyer P, Cote GJ, Busaidy NL, Dadu R, Zafereo M, Williams MD, Ferrarotto R, Gunn GB, Wei P, Patel K, Hofmann MC, Cabanillas ME. Clinical Utility of Circulating Cell-Free DNA Mutations in Anaplastic Thyroid Carcinoma. Thyroid 31(8):1235-1243, 2021. e-Pub 2021. PMID: 33599171.
49. Ballhausen A, Urias E, Gruschkus SK, Williams M, Glover MS, Qin Y, Gombos DS, Patel SP. Metastatic Risk Factors Associated with Class 1A Uveal Melanoma Patients. Cancers (Basel) 13(13), 2021. e-Pub 2021. PMID: 34209210.
50. Choi KY, Amit M, Tam S, Bell D, Phan J, Garden AS, Williams MD, Ferrarotto R, El-Naggar AK, Raza SM, DeMonte F, Kupferman ME, Hanna EY, Su SY. Clinical Implication of Diagnostic and Histopathologic Discrepancies in Sinonasal Malignancies. Laryngoscope 131(5):E1468-E1475, 2021. e-Pub 2021. PMID: 32946597.
51. Williams MD, DeLellis RA, Erickson LA, Gupta R, Johnson SJ, Kameyama K, Natu S, Ng T, Perren A, Perrier ND, Seethala RR, Gill AJ. Pathology data set for reporting parathyroid carcinoma and atypical parathyroid neoplasm: recommendations from the International Collaboration on Cancer Reporting. Hum Pathol 110:73-82, 2021. e-Pub 2021. PMID: 32687943.
52. Bagheri-Yarmand R, Dadu R, Ye L, Jebaraj YS, Martinez JA, Ma J, Tarapore RS, Allen JE, Sherman SI, Williams MD, Gagel RF. ONC201 shows anti-cancer activity against medullary thyroid cancer via transcriptional inhibition of RET, VEGFR2, and IGFBP2. Mol Cancer Ther 20(4):665-675, 2021. e-Pub 2021. PMID: 33536187.
53. Jozaghi Y, Zafereo M, Williams MD, Gule-Monroe MK, Wang J, Grubbs EG, Vaporciyan A, Hu MI, Busaidy N, Dadu R, Waguespack SG, Subbiah V, Cabanillas M. Neoadjuvant selpercatinib for advanced medullary thyroid cancer. Head and Neck 43(1):E7-E12, 2021. e-Pub 2021. PMID: 33169506.
54. Del Valle Estopinal M, Middleton LP, Esmaeli B, Patel KP, Nowroozizadeh S, Williams MD. Primary Signet Ring Cell/Histiocytoid Carcinoma of the Eyelid: Clinicopathologic Analysis with Evaluation of the E-Cadherin/β-Catenin Complex and Associated Genetic Alterations. Case Rep Pathol 2021:6628150, 2021. e-Pub 2021. PMID: 34804623.
55. Williams MD, Ma J, Grubbs EG, Gagel RF, Bagheri-Yarmand R. ATF4 loss of heterozygosity is associated with poor overall survival in medullary thyroid carcinoma. Am J Cancer Res 11(6):3227-3239, 2021. e-Pub 2021. PMID: 34249457.
56. Jin L, Tang Y, Wu Y, Coole JB, Tan MT, Zhao X, Badaoui H, Robinson JT, Williams MD, Gillenwater AM, Richards-Kortum RR, Veeraraghavan A. Deep learning extended depth-of-field microscope for fast and slide-free histology. Proc Natl Acad Sci U S A 117(52):33051-33060, 2020. e-Pub 2020. PMID: 33318169.
57. Pundole X, Jones AL, Tetzlaff MT, Williams MD, Murphy WA Jr, Otun A, Goepfert RP, Davies MA. Osteonecrosis of the jaw induced by treatment with anti-PD-1 immunotherapy: a case report. Immunotherapy 12(17):1213-1219, 2020. e-Pub 2020. PMID: 32900256.
58. Qin Y, Bollin K, de Macedo MP, Carapeto F, Kim KB, Roszik J, Wani KM, Reuben A, Reddy ST, Williams MD, Tetzlaff MT, Wang WL, Gombos DS, Esmaeli B, Lazar AJ, Hwu P, Patel SP. Immune profiling of uveal melanoma identifies a potential signature associated with response to immunotherapy. J Immunother Cancer 8(2), 2020. e-Pub 2020. PMID: 33203661.
59. Maniakas A, Dadu R, Busaidy NL, Wang JR, Ferrarotto R, Lu C, Williams MD, Gunn GB, Hofmann MC, Cote G, Sperling J, Gross ND, Sturgis EM, Goepfert RP, Lai SY, Cabanillas ME, Zafereo M. Evaluation of Overall Survival in Patients With Anaplastic Thyroid Carcinoma, 2000-2019. JAMA Oncol 6(9):1397-1404, 2020. e-Pub 2020. PMID: 32761153.
60. Yang EC, Brenes DR, Vohra IS, Schwarz RA, Williams MD, Vigneswaran N, Gillenwater AM, Richards-Kortum RR. Algorithm to quantify nuclear features and confidence intervals for classification of oral neoplasia from high-resolution optical images. J Med Imaging (Bellingham) 7(5):054502, 2020. e-Pub 2020. PMID: 32999894.
61. Lee DY, Brayer KJ, Mitani Y, Burns EA, Rao PH, Bell D, Williams MD, Ferrarotto R, Pytynia KB, El-Naggar AK, Ness SA. Oncogenic Orphan Nuclear Receptor NR4A3 Interacts and Cooperates with MYB in Acinic Cell Carcinoma. Cancers (Basel) 12(9), 2020. e-Pub 2020. PMID: 32867110.
62. Zafereo M, McIver B, Vargas-Salas S, Domínguez JM, Steward DL, Holsinger FC, Kandil E, Williams M, Cruz F, Loyola S, Solar A, Roa JC, León A, Droppelman N, Lobos M, Arias T, Kong CS, Busaidy N, Grubbs EG, Graham P, Stewart J, Tang A, Wang J, Orloff L, Henríquez M, Lagos M, Osorio M, Schachter D, Franco C, Medina F, Wohllk N, Diaz RE, Veliz J, Horvath E, Tala H, Pineda P, Arroyo P, Vasquez F, Traipe E, Marín L, Miranda G, Bruce E, Bracamonte M, Mena N, González HE. A Thyroid Genetic Classifier Correctly Predicts Benign Nodules With Indeterminate Cytology: Two-Independent Multicenter, Prospective Validation Trials. Thyroid 30(5):704-712, 2020. e-Pub 2020. PMID: 31910118.
63. Chari NS, Ivan C, Le X, Li J, Mijiti A, Patel AA, Osman AA, Peterson CB, Williams MD, Pickering CR, Caulin C, Myers JN, Calin GA, Lai SY. Disruption of TP63-miR-27a* feedback loop by mutant TP53 in head and neck cancer. J Natl Cancer Inst 112(3):266-277, 2020. e-Pub 2020. PMID: 31124563.
64. Yang EC, Vohra IS, Badaoui H, Schwarz RA, Cherry KD, Jacob J, Rodriguez J, Williams MD, Vigneswaran N, Gillenwater AM, Richards-Kortum RR. Prospective evaluation of oral premalignant lesions using a multimodal imaging system: a pilot study. Head Neck 42(2):171-179, 2020. e-Pub 2020. PMID: 31621979.
65. Silva-Figueroa AM, Bassett R, Christakis I, Moreno P, Clarke CN, Busaidy NL, Grubbs EG, Lee JE, Perrier ND, Williams MD. Using a Novel Diagnostic Nomogram to Differentiate Malignant from Benign Parathyroid Neoplasms. Endocr Pathol 30(4):285-296, 2019. e-Pub 2019. PMID: 31734935.
66. Liang L, Williams MD, Bell D. Expression of PTEN, Androgen Receptor, HER2/neu, Cytokeratin 5/6, Estrogen Receptor-Beta, HMGA2, and PLAG1 in Salivary Duct Carcinoma. Head Neck Pathol 13(4):529-534, 2019. e-Pub 2019. PMID: 30390196.
67. Cherry KD, Schwarz RA, Yang EC, Vohra IS, Badaoui H, Williams MD, Vigneswaran N, Gillenwater AM, Richards-Kortum R. Autofluorescence Imaging to Monitor the Progression of Oral Potentially Malignant Disorders. Cancer Prev Res (Phila) 12(11):791-800, 2019. e-Pub 2019. PMID: 31451520.
68. Asare EA, Silva-Figueroa A, Hess KR, Busaidy N, Graham PH, Grubbs EG, Lee JE, Williams MD, Perrier ND. Risk of Distant Metastasis in Parathyroid Carcinoma and Its Effect on Survival: A Retrospective Review from a High-Volume Center. Ann Surg Oncol 26(11):3593-3599, 2019. e-Pub 2019. PMID: 31111352.
69. Wang JR, Zafereo ME, Dadu R, Ferrarotto R, Busaidy NL, Lu C, Ahmed S, Gule-Monroe MK, Williams MD, Sturgis EM, Goepfert RP, Gross ND, Lai SY, Gunn GB, Phan J, Rosenthal DI, Fuller CD, Morrison WH, Iyer P, Cabanillas ME. Complete Surgical Resection Following Neoadjuvant Dabrafenib Plus Trametinib in BRAF(V600E)-Mutated Anaplastic Thyroid Carcinoma. Thyroid 29(8):1036-1043, 2019. e-Pub 2019. PMID: 31319771.
70. Kutahyalioglu M, Nguyen HT, Kwatampora L, Clarke C, Silva A, Ibrahim E, Waguespack SG, Cabanillas ME, Jimenez C, Hu MI, Sherman SI, Kopetz S, Broaddus R, Dadu R, Wanland K, Williams M, Zafereo M, Perrier N, Busaidy NL. Genetic profiling as a clinical tool in advanced parathyroid carcinoma. J Cancer Res Clin Oncol 145(8):1977-1986, 2019. e-Pub 2019. PMID: 31309300.
71. Acharya RP, Won AM, Moon BS, Flint JH, Roubaud MS, Williams MD, Hessel AC, Murphy WA, Chambers MS, Gagel RF. Tumor-induced hypophosphatemic osteomalacia caused by a mesenchymal tumor of the mandible managed by a segmental mandibulectomy and microvascular reconstruction with a free fibula flap. Head Neck 41(6):E93-E98, 2019. e-Pub 2019. PMID: 30859653.
72. Genutis LK, Tomsic J, Bundschuh RA, Brock PL, Williams MD, Roychowdhury S, Reeser JW, Frankel WL, Alsomali M, Routbort MJ, Broaddus RR, Wakely PE, Phay JE, Walker CJ, de la Chapelle A. Microsatellite Instability Occurs in a Subset of Follicular Thyroid Cancers. Thyroid 29(4):523-529, 2019. e-Pub 2019. PMID: 30747051.
73. Clarke CN, Katsonis P, Hsu TK, Koire AM, Silva-Figueroa A, Christakis I, Williams MD, Kutahyalioglu M, Kwatampora L, Xi Y, Lee JE, Koptez ES, Busaidy NL, Perrier ND, Lichtarge O. Comprehensive Genomic Characterization of Parathyroid Cancer Identifies Novel Candidate Driver Mutations and Core Pathways. J Endocr Soc 3(3):544-559, 2019. e-Pub 2019. PMID: 30788456.
74. Ye W, Hannigan B, Zalles S, Mehrotra M, Barkoh BA, Williams MD, Cabanillas ME, Edeiken-Monroe B, Hu P, Duose D, Wistuba II, Medeiros LJ, Stewart J, Luthra R, Roy-Chowdhuri S. Centrifuged supernatants from FNA provide a liquid biopsy option for clinical next-generation sequencing of thyroid nodules. Cancer Cytopathol 127(3):146-160, 2019. e-Pub 2019. PMID: 30620446.
75. Haddad RI, Massarelli E, Lee JJ, Lin HY, Hutcheson K, Lewis J, Garden AS, Blumenschein GR, William WN, Pharaon RR, Tishler RB, Glisson BS, Pickering C, Gold KA, Johnson FM, Rabinowits G, Ginsberg LE, Williams MD, Myers J, Kies MS, Papadimitrakopoulou V. Weekly paclitaxel, carboplatin, cetuximab, and cetuximab, docetaxel, cisplatin, and fluorouracil, followed by local therapy in previously untreated, locally advanced head and neck squamous cell carcinoma. Ann Oncol 30(3):471-477, 2019. e-Pub 2019. PMID: 30596812.
76. Guo M, Khanna A, Wang J, Williams MD, Kalhor N, Gong Y, Xu L, Sturgis EM, Staerkel G. Incorporation of Cervista Human Papillomavirus 16/18 Assay Into Algorithms for Classifying Human Papillomavirus Status in Formalin-Fixed, Paraffin-Embedded Head and Neck Squamous Carcinoma Specimens. Arch Pathol Lab Med 143(3):356-361, 2019. e-Pub 2019. PMID: 30221979.
77. Nikiforova MN, Nikitski AV, Panebianco F, Kaya C, Yip L, Williams MD, Chiosea SI, Seethala RR, Roy S, Condello V, Santana-Santos L, Wald AI, Carty SE, Ferris RL, El-Naggar AK, Nikiforov YE. GLIS Rearrangement is a Genomic Hallmark of Hyalinizing Trabecular Tumor of the Thyroid Gland. Thyroid 29(2):161-173, 2019. e-Pub 2019. PMID: 30648929.
78. Yang EC, Vohra IS, Badaoui H, Schwarz RA, Cherry KD, Quang T, Jacob J, Lang A, Bass N, Rodriguez J, Williams MD, Vigneswaran N, Gillenwater AM, Richards-Kortum RR. Development of an integrated multimodal optical imaging system with real-time image analysis for the evaluation of oral premalignant lesions. J Biomed Opt 24(2):1-10, 2019. e-Pub 2019. PMID: 30793567.
79. Fisher SB, Cote GJ, Bui-Griffith JH, Lu W, Tang X, Hai T, Fisher KE, Williams MD, Wistuba II, Waguespack SG, Dorman CM, Ludwig MS, Graham PH, Perrier ND, Lee JE, Grubbs EG. Genetic characterization of medullary thyroid cancer in childhood survivors of the Chernobyl accident. Surgery 165(1):58-63, 2019. e-Pub 2019. PMID: 30392857.
80. Iyer PC, Cote GJ, Hai T, Gule-Monroe M, Bui-Griffith J, Williams MD, Hess K, Hofmann MC, Dadu R, Zafereo M, Busaidy NL, Ferrarotto R, Subbiah V, Gross N, Gunn BG, Skinner HD, Garden AS, Cabanillas ME. Circulating BRAF V600E Cell-Free DNA as a Biomarker in the Management of Anaplastic Thyroid Carcinoma. JCO Precis Oncol 2, 2018. e-Pub 2018. PMID: 35135166.
81. Silva-Figueroa A, Villalobos P, Williams MD, Bassett RL, Clarke CN, Lee JE, Busaidy NL, Perrier ND. Characterizing parathyroid carcinomas and atypical neoplasms based on the expression of programmed death-ligand 1 expression and the presence of tumor-infiltrating lymphocytes and macrophages. Surgery 164(5):960-964, 2018. e-Pub 2018. PMID: 30033186.
82. Tam S, Boonsripitayanon M, Amit M, Fellman BM, Li Y, Busaidy NL, Cabanillas ME, Dadu R, Sherman S, Waguespack SG, Williams MD, Goepfert RP, Gross ND, Perrier ND, Sturgis EM, Zafereo ME. Survival in Differentiated Thyroid Cancer: Comparing the AJCC Cancer Staging Seventh and Eighth Editions. Thyroid 28(10):1301-1310, 2018. e-Pub 2018. PMID: 30141373.
83. Said RB, Williams MD, Edeiken-Monroe BS, Fornage BD, Sturgis EM, Debnam JM. Myofibrosarcoma Mimicking a Vascular Thrombosis: A Case Report. Ultrasound Int Open 4(4):E136-E138, 2018. e-Pub 2018. PMID: 30370400.
84. Amit M, Boonsripitayanon M, Goepfert RP, Tam S, Busaidy NL, Cabanillas ME, Dadu R, Varghese J, Waguespack SG, Gross ND, Graham P, Williams MD, Sturgis EM, Zafereo ME. Extrathyroidal Extension: Does Strap Muscle Invasion Alone Influence Recurrence and Survival in Patients with Differentiated Thyroid Cancer?. Ann Surg Oncol 25(11):3380-3388, 2018. e-Pub 2018. PMID: 30022274.
85. Yang EC, Schwarz RA, Lang AK, Bass N, Badaoui H, Vohra IS, Cherry KD, Williams MD, Gillenwater AM, Vigneswaran N, Richards-Kortum RR. In Vivo Multimodal Optical Imaging: Improved Detection of Oral Dysplasia in Low-Risk Oral Mucosal Lesions. Cancer Prev Res (Phila) 11(8):465-476, 2018. e-Pub 2018. PMID: 29903741.
86. Iyer PC, Dadu R, Gule-Monroe M, Busaidy NL, Ferrarotto R, Habra MA, Zafereo M, Williams MD, Gunn GB, Grosu H, Skinner HD, Sturgis EM, Gross N, Cabanillas ME. Salvage pembrolizumab added to kinase inhibitor therapy for the treatment of anaplastic thyroid carcinoma. J Immunother Cancer 6(1):68, 2018. e-Pub 2018. PMID: 29996921.
87. Chen H, Luthra R, Routbort MJ, Patel KP, Cabanillas ME, Broaddus RR, Williams MD. Molecular Profile of Advanced Thyroid Carcinomas by Next-Generation Sequencing: Characterizing Tumors Beyond Diagnosis for Targeted Therapy. Mol Cancer Ther 17(7):1575-1584, 2018. e-Pub 2018. PMID: 29695638.
88. Cabanillas ME, Ferrarotto R, Garden AS, Ahmed S, Busaidy NL, Dadu R, Williams MD, Skinner H, Gunn GB, Grosu H, Iyer P, Hofmann MC, Zafereo M. Neoadjuvant BRAF- and Immune-Directed Therapy for Anaplastic Thyroid Carcinoma. Thyroid 28(7):945-951, 2018. e-Pub 2018. PMID: 29742974.
89. Ng SP, Johnson JM, Gunn GB, Rosenthal DI, Skinner HD, Phan J, Frank SJ, Morrison W, Sturgis EM, Mott FE, Williams MD, Fuller CD, Garden AS. Significance of Negative Post-Treatment 18-FDG PET/CT Imaging in Patients with p16/HPV-positive Oropharyngeal Cancer. Int J Radiat Oncol Biol Phys. e-Pub 2018. PMID: 29960060.
90. Tam S, Amit M, Boonsripitayanon M, Busaidy N, Cabanillas M, Waguespack SG, Gross ND, Grubbs EG, Williams MD, Lai SY, Sturgis E, Zafereo M. The Effect of Tumor Size and Minimal Extrathyroidal Extension in Patients with Differentiated Thyroid Cancer. Thyroid. e-Pub 2018. PMID: 29936892.
91. Smith AL, Williams MD, Stewart J, Wang WL, Krishnamurthy S, Cabanillas ME, Roy-Chowdhuri S. Utility of the BRAF p.V600E immunoperoxidase stain in FNA direct smears and cell block preparations from patients with thyroid carcinoma. Cancer Cytopathol 126(6):406-413, 2018. e-Pub 2018. PMID: 29579361.
92. Ahmed S, Ghazarian MP, Cabanillas ME, Zafereo ME, Williams MD, Vu T, Schomer DF, Debnam JM. Imaging of Anaplastic Thyroid Carcinoma. AJNR Am J Neuroradiol 39(3):547-551, 2018. e-Pub 2018. PMID: 29242360.
93. Robertson AG, Shih J, Yau C, Gibb EA, Oba J, Mungall KL, Hess JM, Uzunangelov V, Walter V, Danilova L, Lichtenberg TM, Kucherlapati M, Kimes PK, Tang M, Penson A, Babur O, Akbani R, Bristow CA, Hoadley KA, Iype L, Chang MT, Network TR, Cherniack AD, Benz C, Mills GB, Verhaak RGW, Griewank KG, Felau I, Zenklusen JC, Gershenwald JE, Schoenfield L, Lazar AJ, Abdel-Rahman MH, Roman-Roman S, Stern MH, Cebulla CM, Williams MD, Jager J, Coupland SE, Esmaeli B, Kandoth C, Woodman SE. Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma. Cancer Cell 32(2):204-220, 2018. e-Pub 2018. PMID: 29316429.
94. Iyer PC, Dadu R, Ferrarotto R, Busaidy NL, Habra MA, Zafereo M, Gross N, Hess KR, Gule-Monroe M, Williams MD, Cabanillas ME. Real-World Experience with Targeted Therapy for the Treatment of Anaplastic Thyroid Carcinoma. Thyroid 28(1):79-87, 2018. e-Pub 2018. PMID: 29161986.
95. Iyer PC, Dadu R, Ferrarotto R, Busaidy NL, Habra MA, Zafereo M, Gross N, Hess KR, Gule-Monroe M, Williams MD, Cabanillas ME. Real-World Experience with Targeted Therapy for the Treatment of Anaplastic Thyroid Carcinoma. Thyroid 28(1):79-87, 2018. e-Pub 2018. PMID: 29161986.
96. Valenciaga A, Grubbs EG, Porter K, Wakely PE Jr, Williams MD, Cote GJ, Vasko VV, Saji M, Ringel MD. Reduced Retinoblastoma Protein Expression Is Associated with Decreased Patient Survival in Medullary Thyroid Cancer. Thyroid 27(12):1523-1533, 2017. e-Pub 2017. PMID: 29105562.
97. Christakis I, Silva AM, Williams MD, Garden A, Grubbs EG, Busaidy NL, Lee JE, Perrier ND, Zafereo M. Postoperative local-regional radiation therapy in the treatment of parathyroid carcinoma: The MD Anderson experience of 35 years. Pract Radiat Oncol 7(6):e463-e470, 2017. e-Pub 2017. PMID: 28751227.
98. Christakis I, Vu T, Chuang HH, Fellman B, Figueroa AMS, Williams MD, Busaidy NL, Perrier ND. The diagnostic accuracy of neck ultrasound, 4D-Computed tomography and sestamibi imaging in parathyroid carcinoma. Eur J Radiol 95:82-88, 2017. e-Pub 2017. PMID: 28987702.
99. Quang T, Tran EQ, Schwarz RA, Williams MD, Vigneswaran N, Gillenwater AM, Richards-Kortum R. Prospective Evaluation of Multimodal Optical Imaging with Automated Image Analysis to Detect Oral Neoplasia In Vivo. Cancer Prev Res (Phila) 10(10):563-570, 2017. e-Pub 2017. PMID: 28765195.
100. Cote GJ, Evers C, Hu MI, Grubbs EG, Williams MD, Hai T, Duose DY, Houston MR, Bui JH, Mehrotra M, Waguespack SG, Busaidy NL, Cabanillas ME, Habra MA, Luthra R, Sherman SI. Prognostic Significance of Circulating RET M918T Mutated Tumor DNA in Patients with Advanced Medullary Thyroid Carcinoma. J Clin Endocrinol Metab 102(9):3591-3599, 2017. e-Pub 2017. PMID: 28911154.
101. Robertson AG, Shih J, Yau C, Gibb EA, Oba J, Mungall KL, Hess JM, Uzunangelov V, Walter V, Danilova L, Lichtenberg TM, Kucherlapati M, Kimes PK, Tang M, Penson A, Babur O, Akbani R, Bristow CA, Hoadley KA, Iype L, Chang MT, Cherniack AD, Benz C, Mills GB, Verhaak RGW, Griewank KG, Felau I, Zenklusen JC, Gershenwald JE, Schoenfield L, Lazar AJ, Abdel-Rahman MH, Roman-Roman S, Stern MH, Cebulla CM, Williams MD, Jager MJ, Coupland SE, Esmaeli B, Kandoth C, Woodman SE. Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma. Cancer Cell 32(2):204-220.e15, 2017. e-Pub 2017. PMID: 28810145.
102. Skinner HD, Giri U, Yang LP, Kumar M, Liu Y, Story MD, Pickering CR, Byers LA, Williams MD, Wang J, Shen L, Yoo SY, Fan YH, Molkentine DP, Beadle BM, Meyn RE, Myers JN, Heymach JV. Integrative Analysis Identifies a Novel AXL-PI3 Kinase-PD-L1 Signaling Axis Associated with Radiation Resistance in Head and Neck Cancer. Clin Cancer Res 23(11):2713-2722, 2017. e-Pub 2017. PMID: 28476872.
103. Pezzi TA, Mohamed ASR, Sheu T, Blanchard P, Sandulache VC, Lai SY, Cabanillas ME, Williams MD, Pezzi CM, Lu C, Garden AS, Morrison WH, Rosenthal DI, Fuller CD, Gunn GB. Radiation therapy dose is associated with improved survival for unresected anaplastic thyroid carcinoma: Outcomes from the National Cancer Data Base. Cancer 123(9):1653-1661, 2017. e-Pub 2017. PMID: 28026871.
104. Rao SN, Zafereo M, Dadu R, Busaidy NL, Hess K, Cote GJ, Williams MD, William WN, Sandulache V, Gross N, Gunn GB, Lu C, Ferrarotto R, Lai SY, Cabanillas ME. Patterns of Treatment Failure in Anaplastic Thyroid Carcinoma. Thyroid 27(5):672-681, 2017. e-Pub 2017. PMID: 28068873.
105. Haugen BR, Sawka AM, Alexander EK, Bible KC, Caturegli P, Doherty GM, Mandel SJ, Morris JC, Nassar A, Pacini F, Schlumberger M, Schuff K, Sherman SI, Somerset H, Sosa JA, Steward DL, Wartofsky L, Williams MD. The ATA Guidelines on Management of Thyroid Nodules and Differentiated Thyroid Cancer Task Force Review and Recommendation on the Proposed Renaming of eFVPTC without Invasion to NIFTP. Thyroid 27(4):481-483, 2017. e-Pub 2017. PMID: 28114862.
106. Jittapiromsak N, Hou P, Williams MD, Chi TL. Orbital oncocytoma: evaluation with dynamic contrast-enhanced magnetic resonance imaging using a time-signal intensity curve and positive enhancement integral images. Clin Imaging 42:161-164, 2017. e-Pub 2017. PMID: 28063355.
107. Williams MD. Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Mucosal Melanomas. Head Neck Pathol 11(1):110-117, 2017. e-Pub 2017. PMID: 28247222.
108. Silva-Figueroa AM, Hess KR, Williams MD, Clarke CN, Christakis I, Graham PH, Grubbs EG, Lee JE, Busaidy NL, Perrier ND. Prognostic Scoring System to Risk Stratify Parathyroid Carcinoma. J Am Coll Surg. e-Pub 2017. PMID: 28427885.
109. Williams MD, Tischler AS. Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Paragangliomas. Head Neck Pathol 11(1):88-95, 2017. e-Pub 2017. PMID: 28247224.
110. Bagheri-Yarmand R, Williams MD, Grubbs EG, Gagel RF. ATF4 Targets RET for Degradation and is a Candidate Tumor Suppressor Gene in Medullary Thyroid Cancer. J Clin Endocrinol Metab 102(3):jc20162878, 2017. e-Pub 2017. PMID: 27935748.
111. Sandulache VC, Williams MD, Lai SY, Lu C, William WN, Busaidy NL, Cote GJ, Singh RR, Luthra R, Cabanillas ME. Real-Time Genomic Characterization Utilizing Circulating Cell-Free DNA in Patients with Anaplastic Thyroid Carcinoma. Thyroid 27(1):81-87, 2017. e-Pub 2017. PMID: 27785980.
112. Qin Y, Petaccia de Macedo M, Reuben A, Forget MA, Haymaker C, Bernatchez C, Spencer CN, Gopalakrishnan V, Reddy S, Cooper ZA, Fulbright OJ, Ramachandran R, Wahl A, Flores E, Thorsen ST, Tavera RJ, Conrad C, Williams MD, Tetzlaff MT, Wang WL, Gombos DS, Esmaeli B, Amaria RN, Hwu P, Wargo JA, Lazar AJ, Patel SP. Parallel profiling of immune infiltrate subsets in uveal melanoma versus cutaneous melanoma unveils similarities and differences: A pilot study. Oncoimmunology 6(6):e1321187, 2017. e-Pub 2017. PMID: 28680759.
113. Christakis I, Silva AM, Kwatampora LJ, Warneke CL, Clarke CN, Williams MD, Grubbs EG, Lee JE, Busaidy NL, Perrier ND. Oncologic progress for the treatment of parathyroid carcinoma is needed. J Surg Oncol 114(6):708-713, 2016. e-Pub 2016. PMID: 27753088.
114. Grubbs EG, Williams MD, Scheet P, Vattathil S, Perrier ND, Lee JE, Gagel RF, Hai T, Feng L, Cabanillas ME, Cote GJ. Role of CDKN2C Copy Number in Sporadic Medullary Thyroid Carcinoma. Thyroid 26(11):1553-1562, 2016. e-Pub 2016. PMID: 27610696.
115. Christakis I, Bussaidy N, Clarke C, Kwatampora LJ, Warneke CL, Silva AM, Williams MD, Grubbs EG, Lee JE, Perrier ND. Differentiating Atypical Parathyroid Neoplasm from Parathyroid Cancer. Ann Surg Oncol 23(9):2889-97, 2016. e-Pub 2016. PMID: 27160525.
116. Christakis I, Qiu W, Silva Figueroa AM, Hyde S, Cote GJ, Busaidy NL, Williams M, Grubbs E, Lee JE, Perrier ND. Clinical Features, Treatments, and Outcomes of Patients with Thymic Carcinoids and Multiple Endocrine Neoplasia Type 1 Syndrome at MD Anderson Cancer Center. Horm Cancer 7(4):279-87, 2016. e-Pub 2016. PMID: 27311764.
117. Christakis I, Busaidy NL, Cote GJ, Williams MD, Hyde SM, Silva Figueroa AM, Kwatampora LJ, Clarke CN, Qiu W, Lee JE, Perrier ND. Parathyroid carcinoma and atypical parathyroid neoplasms in MEN1 patients; A clinico-pathologic challenge. The MD Anderson case series and review of the literature. Int J Surg 31:10-6, 2016. e-Pub 2016. PMID: 27212590.
118. Pezzi TA, Sandulache VC, Pezzi CM, Turkeltaub AE, Feng L, Cabanillas ME, Williams MD, Lai SY. Treatment and survival of patients with insular thyroid carcinoma: 508 cases from the National Cancer Data Base. Head Neck 38(6):906-12, 2016. e-Pub 2016. PMID: 26843481.
119. Skinner HD, Giri U, Yang L, Woo SH, Story MD, Pickering CR, Byers LA, Williams MD, El-Naggar A, Wang J, Diao L, Shen L, Fan YH, Molkentine DP, Beadle BM, Meyn RE, Myers JN, Heymach JV. Proteomic Profiling Identifies PTK2/FAK as a Driver of Radioresistance in HPV-negative Head and Neck Cancer. Clin Cancer Res. e-Pub 2016. PMID: 27036135.
120. Bell D, Hanna EY, Weber RS, DeMonte F, Triantafyllou A, Lewis JS, Cardesa A, Slootweg PJ, Stenman G, Gnepp DR, Devaney KO, Rodrigo JP, Rinaldo A, Wenig BM, Westra WH, Bishop JA, Hellquist H, Hunt JL, Kusafuka K, Perez-Ordoñez B, Williams MD, Takes RP, Ferlito A. Neuroendocrine Neoplasms of the Sinonasal Region. Head Neck 38 Suppl 1:E2259-66, 2016. e-Pub 2016. PMID: 26041714.
121. Hashmi SS, Guha-Thakurta N, Ketonen L, Williams MD, Shah S, Debnam JM. Central Nervous System and Head and Neck Histiocytoses: A Comprehensive Review on the Spectrum of Imaging Findings. Neurographics (2011) 6(2):114-122, 2016. e-Pub 2016. PMID: 30417172.
122. Guo M, Khanna A, Patel S, Williams M, Sturgis E, Gong Y, Staerkel G. Cervista HPV 16/18 and HPV HR assays can be used in tissue specimens of oropharyngeal squamous carcinoma patients to determine high-risk HPV status. Pathology 48 Suppl 1:S127-S128, 2016. e-Pub 2016. PMID: 27772854.
123. Estrella JS, Tetzlaff MT, Bassett RL Jr, Patel KP, Williams MD, Curry JL, Rashid A, Hamilton SR, Broaddus RR. Assessment of BRAF V600E Status in Colorectal Carcinoma: Tissue-Specific Discordances between Immunohistochemistry and Sequencing. Mol Cancer Ther 14(12):2887-95, 2015. e-Pub 2015. PMID: 26438153.
124. Bishop JA, Thompson LD, Cardesa A, Barnes L, Lewis JS, Triantafyllou A, Hellquist H, Stenman G, Hunt JL, Williams MD, Slootweg PJ, Devaney KO, Gnepp DR, Wenig BM, Rinaldo A, Ferlito A. Rhabdomyoblastic Differentiation in Head and Neck Malignancies Other Than Rhabdomyosarcoma. Head Neck Pathol 9(4):507-18, 2015. e-Pub 2015. PMID: 25757816.
125. George JR, Henderson YC, Williams MD, Roberts DB, Hei H, Lai SY, Clayman GL. Association of TERT Promoter Mutation, But Not BRAF Mutation, With Increased Mortality in PTC. J Clin Endocrinol Metab 100(12):E1550-9, 2015. e-Pub 2015. PMID: 26461266.
126. Triantafyllou A, Williams MD, Angelos P, Shah JP, Westra WH, Hunt JL, Devaney KO, Rinaldo A, Slootweg PJ, Gnepp DR, Silver C, Ferlito A. Incidental Findings of Thyroid Tissue in Cervical Lymphnodes: Old Controversy Not Yet Resolved?. Eur Arch Otorhinolaryngol. e-Pub 2015. PMID: 26459007.
127. Dahlstrom KR, Bell D, Hanby D, Li G, Wang LE, Wei Q, Williams MD, Sturgis EM. Socioeconomic characteristics of patients with oropharyngeal carcinoma according to tumor HPV status, patient smoking status, and sexual behavior. Oral Oncol 51(9):832-8, 2015. e-Pub 2015. PMID: 26120093.
128. Tetzlaff MT, Pattanaprichakul P, Wargo J, Fox PS, Patel KP, Estrella JS, Broaddus RR, Williams MD, Davies MA, Routbort MJ, Lazar AJ, Woodman SE, Hwu WJ, Gershenwald JE, Prieto VG, Torres-Cabala CA, Curry JL. Utility of BRAF V600E Immunohistochemistry Expression Pattern as a Surrogate of BRAF Mutation Status in 154 Patients with Advanced Melanoma. Hum Pathol 46(8):1101-10, 2015. e-Pub 2015. PMID: 26058727.
129. Massarelli E, Lin H, Ginsberg LE, Tran HT, Lee JJ, Canales JR, Williams MD, Blumenschein GR, Lu C, Heymach JV, Kies MS, Papadimitrakopoulou V. Phase II trial of everolimus and erlotinib in patients with platinum-resistant recurrent and/or metastatic head and neck squamous cell carcinoma. Ann Oncol 26(7):1476-80, 2015. e-Pub 2015. PMID: 26025965.
130. Bagheri-Yarmand R, Sinha KM, Gururaj AE, Ahmed Z, Rizvi YQ, Huang SC, Ladbury JE, Bogler O, Williams MD, Cote GJ, Gagel RF. A Novel Dual Kinase Function of the RET Proto-oncogene Negatively Regulates Activating Transcription Factor 4-mediated Apoptosis. J Biol Chem 290(18):11749-61, 2015. e-Pub 2015. PMID: 25795775.
131. Recondo G Jr, Busaidy N, Erasmus J, Williams MD, Johnson FM. Spindle epithelial tumor with thymus-like differentiation: A case report and comprehensive review of the literature and treatment options. Head Neck 37(5):746-54, 2015. e-Pub 2015. PMID: 24677409.
132. Grubbs EG, Ng PK, Bui J, Busaidy NL, Chen K, Lee JE, Lu X, Lu H, Meric-Bernstam F, Mills GB, Palmer G, Perrier ND, Scott KL, Shaw KR, Waguespack SG, Williams MD, Yelensky R, Cote GJ. RET fusion as a novel driver of medullary thyroid carcinoma. J Clin Endocrinol Metab 100(3):jc20144153, 2015. e-Pub 2015. PMID: 25546157.
133. Henderson YC, Ahn SH, Ryu J, Chen Y, Williams MD, El-Naggar AK, Gagea M, Schweppe RE, Haugen BR, Lai SY, Clayman GL. Development and Characterization of Six New Human Papillary Thyroid Carcinoma Cell Lines. J Clin Endocrinol Metab 100(2):jc20142624, 2015. e-Pub 2015. PMID: 25427145.
134. Research Network CGA. Integrated genomic characterization of papillary thyroid carcinoma. Cell 159(3):676-90, 2014. e-Pub 2014. PMID: 25417114.
135. Woolgar JA, Triantafyllou A, Thompson LD, Hunt JL, Lewis JS, Williams MD, Cardesa A, Rinaldo A, Barnes L, Slootweg PJ, Devaney KO, Gnepp DR, Westra WH, Ferlito A. Double reporting and second opinion in head and neck pathology. Eur Arch Otorhinolaryngol 271(5):847-54, 2014. e-Pub 2014. PMID: 24435586.
136. Shawa H, Elsayes KM, Javadi S, Morani A, Williams MD, Lee JE, Waguespack SG, Busaidy NL, Vassilopoulou-Sellin R, Jimenez C, Habra MA. Adrenal ganglioneuroma: features and outcomes of 27 cases at a referral cancer centre. Clin Endocrinol (Oxf) 80(3):342-7, 2014. e-Pub 2014. PMID: 24033606.
137. Guo M, Khanna A, Dhillon J, Patel SJ, Feng J, Williams MD, Bell DM, Gong Y, Katz RL, Sturgis EM, Staerkel GA. Cervista HPV assays for fine-needle aspiration specimens are a valid option for human papillomavirus testing in patients with oropharyngeal carcinoma. Cancer Cytopathol 122(2):96-103, 2014. e-Pub 2014. PMID: 24339259.
138. Ahn SH, Henderson YC, Williams MD, Lai SY, Clayman GL. Detection of Thyroid Cancer Stem Cells in Papillary Thyroid Carcinoma. J Clin Endocrinol Metab 99(2):536-44, 2014. e-Pub 2014. PMID: 24302752.
139. Sandulache VC, Chen Y, Lee J, Rubinstein A, Ramirez MS, Skinner HD, Walker CM, Williams MD, Tailor R, Court LE, Bankson JA, Lai SY. Evaluation of hyperpolarized [1-¹³C]-pyruvate by magnetic resonance to detect ionizing radiation effects in real time. PLoS One 9(1):e87031, 2014. e-Pub 2014. PMID: 24475215.
140. Shih IH, Duan XD, Kong FL, Williams MD, Yang K, Zhang YH, Yang DJ. Automated synthesis of 18F-fluoropropoxytryptophan for amino acid transporter system imaging. Biomed Res Int 2014:492545, 2014. e-Pub 2014. PMID: 25136592.
141. Beadle BM, William WN Jr, McLemore MS, Sturgis EM, Williams MD. p16 expression in cutaneous squamous carcinomas with neck metastases: a potential pitfall in identifying unknown primaries of the head and neck. Head Neck 35(11):1527-33, 2013. e-Pub 2013. PMID: 23108906.
142. Kim KB, Cabanillas ME, Lazar AJ, Williams MD, Sanders DL, Ilagan JL, Nolop K, Lee RJ, Sherman SI. Clinical Responses to Vemurafenib in Patients with Metastatic Papillary Thyroid Cancer Harboring V600E BRAF mutation. Thyroid 23(10):1277-83, 2013. e-Pub 2013. PMID: 23489023.
143. Peng S, Creighton CJ, Zhang Y, Sen B, Mazumdar T, Myers JN, Lai SY, Woolfson A, Lorenzi MV, Bell D, Williams MD, Johnson FM. Tumor grafts derived from patients with head and neck squamous carcinoma authentically maintain the molecular and histologic characteristics of human cancers. J Transl Med 11(1):198, 2013. e-Pub 2013. PMID: 23981300.
144. Khoury JD, Tannir NM, Williams MD, Chen Y, Yao H, Zhang J, Thompson EJ, Meric-Bernstam F, Medeiros LJ, Weinstein JN, Su X. Landscape of DNA virus associations across human malignant cancers: analysis of 3,775 cases using RNA-Seq. J Virol 87(16):8916-26, 2013. e-Pub 2013. PMID: 23740984.
145. Bedard N, Schwarz RA, Hu A, Bhattar V, Howe J, Williams MD, Gillenwater AM, Richards-Kortum R, Tkaczyk TS. Multimodal snapshot spectral imaging for oral cancer diagnostics: a pilot study. Biomed Opt Express 4(6):938-49, 2013. e-Pub 2013. PMID: 23760882.
146. Woolgar JA, Triantafyllou A, Lewis JS, Hunt J, Williams MD, Takes RP, Thompson LD, Slootweg PJ, Devaney KO, Ferlito A. Prognostic biological features in neck dissection specimens. Eur Arch Otorhinolaryngol 270(5):1581-1592, 2013. e-Pub 2013. PMID: 22983222.
147. Gomez-Rivera F, Fakhri S, Williams MD, Hanna EY, Kupferman ME. Surgical management of sinonasal hemangiopericytomas: a case series. Head Neck 34(10):1492-6, 2012. e-Pub 2012. PMID: 22021153.
148. Shinder R, Nasser QJ, Gutman J, Brejt S, Williams MD, Esmaeli B. Idiopathic Inflammation of the Orbit and Contiguous Structures. Ophthalmic Plast Reconstr Surg 28(4):e82-5, 2012. e-Pub 2012. PMID: 22082592.
149. Pierce MC, Schwarz RA, Bhattar VS, Mondrik S, Williams MD, Lee JJ, Richards-Kortum R, Gillenwater AM. Accuracy of in vivo multimodal optical imaging for detection of oral neoplasia. Cancer Prev Res (Phila) 5(6):801-9, 2012. e-Pub 2012. PMID: 22551901.
150. Rosbach KJ, Williams MD, Gillenwater AM, Richards-Kortum RR. Optical molecular imaging of multiple biomarkers of epithelial neoplasia: epidermal growth factor receptor expression and metabolic activity in oral mucosa. Transl Oncol 5(3):160-71, 2012. e-Pub 2012. PMID: 22741035.
151. Nasser QJ, Gombos DS, Williams MD, Guadagnolo BA, Morrison WH, Garden AS, Beadle BM, Canseco E, Esmaeli B. Management of radiation-induced severe anophthalmic socket contracture in patients with uveal melanoma. Ophthalmic Plast Reconstr Surg 28(3):208-12, 2012. e-Pub 2012. PMID: 22581085.
152. El-Sawy T, Savar A, Williams MD, De Monte F, Esmaeli B. Prognostic Accuracy of the Seventh Edition vs. Sixth Edition of the American Joint Committee on Cancer Tumor Classification for Adenoid Cystic Carcinoma of the Lacrimal Gland. Arch Ophthalmol 130(5):664-6, 2012. e-Pub 2012. PMID: 22652862.
153. Joggerst KH, Langford LA, Williams MD. Aggressive Meningiomas Involving the Parotid Gland. Ann Diagn Pathol 16(2):85-90, 2012. e-Pub 2012. PMID: 22056040.
154. Muldoon TJ, Roblyer D, Williams MD, Stepanek VM, Richards-Kortum R, Gillenwater AM. Noninvasive Imaging of Oral Neoplasia with a High-Resolution Fiber-optic Microendoscope. Head Neck 34(3):305-12, 2012. e-Pub 2012. PMID: 21413101.
155. Thariat J, Ang KK, Allen PK, Ahamad A, Williams MD, Myers JN, El-Naggar AK, Ginsberg LE, Rosenthal DI, Glisson BS, Morrison WH, Weber RS, Garden AS. Prediction of neck dissection requirement after definitive radiotherapy for head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 82(3):e367-74, 2012. e-Pub 2012. PMID: 22284033.
156. Moretti L, Medeiros LJ, Kunkalla K, Williams MD, Singh RR, Vega F. N-terminal PAX8 polyclonal antibody shows cross-reactivity with N-terminal region of PAX5 and is responsible for reports of PAX8 positivity in malignant lymphomas. Mod Pathol 25(2):231-6, 2012. e-Pub 2012. PMID: 22037256.
157. Sedrak P, Ketonen L, Hou P, Guha-Thakurta N, Williams MD, Kurzrock R, Debnam JM. Erdheim-Chester disease of the central nervous system: new manifestations of a rare disease. AJNR Am J Neuroradiol 32(11):2126-31, 2011. e-Pub 2011. PMID: 21960492.
158. Williams MD, Zhang L, Elliott DD, Perrier ND, Lozano G, Clayman GL, El-Naggar AK. Differential Gene Expression Profiling of Aggressive and Nonaggressive Follicular Carcinomas. Hum Pathol 42(9):1213-20, 2011. e-Pub 2011. PMID: 21420716.
159. Moore MW, Jantharapattana K, Williams MD, Grant DG, Selber JC, Holsinger FC. Retropharyngeal lymphadenectomy with transoral robotic surgery for papillary thyroid cancer. J Robot Surg 5(3):221, 2011. e-Pub 2011. PMID: 27637712.
160. Moeller BJ, Yordy JS, Williams MD, Giri U, Raju U, Molkentine DP, Byers LA, Heymach JV, Story MD, Lee JJ, Sturgis EM, Weber RS, Garden AS, Ang KK, Schwartz DL. DNA repair biomarker profiling of head and neck cancer: Ku80 expression predicts locoregional failure and death following radiotherapy. Clin Cancer Res 17(7):2035-43, 2011. e-Pub 2011. PMID: 21349997.
161. Frederick MJ, VanMeter AJ, Gadhikar MA, Henderson YC, Yao H, Pickering CC, Williams MD, El-Naggar AK, Sandulache V, Tarco E, Myers JN, Clayman GL, Liotta LA, Petricoin EF, Calvert VS, Fodale V, Wang J, Weber RS. Phosphoproteomic Analysis of Signaling Pathways in Head and Neck Squamous Cell Carcinoma Patient Samples. Am J Pathol 178(2):548-71, 2011. e-Pub 2011. PMID: 21281788.
162. Sen B, Peng S, Saigal B, Williams MD, Johnson FM. Distinct Interactions Between c-Src and c-Met in Mediating Resistance to c-Src Inhibition in Head and Neck Cancer. Clin Cancer Res 17(3):514-24, 2011. e-Pub 2011. PMID: 21106725.
163. Kupferman ME, de la Garza GO, Santillan AA, Williams MD, Varghese BT, Huh W, Roberts D, Weber RS. Outcomes of Pediatric Patients with Malignancies of the Major Salivary Glands. Ann Surg Oncol 17(12):3301-7, 2010. e-Pub 2010. PMID: 20585877.
164. Grisdale K, Ritterhouse M, Hunter K, Williams MD, Groves MD. Tonsillar pseudotumor: complications of chronically-administered temozolomide. J Neurooncol 100(3):475-9, 2010. e-Pub 2010. PMID: 20440539.
165. Moeller BJ, Rana V, Cannon BA, Williams MD, Sturgis EM, Ginsberg LE, Macapinlac HA, Lee JJ, Ang KK, Chao KS, Chronowski GM, Frank SJ, Morrison WH, Rosenthal DI, Weber RS, Garden AS, Lippman SM, Schwartz DL. Prospective Imaging Assessment of Mortality Risk After Head-and-Neck Radiotherapy. Int J Radiat Oncol Biol Phys 78(3):667-74, 2010. e-Pub 2010. PMID: 20171802.
166. Williams MD, Al-Zubidi N, Debnam JM, Shinder R, DeMonte F, Esmaeli B. Bone invasion by adenoid cystic carcinoma of the lacrimal gland: preoperative imaging assessment and surgical considerations. Ophthalmic Plast Reconstr Surg 26(6):403-8, 2010. e-Pub 2010. PMID: 20924298.
167. Roblyer D, Kurachi C, Stepanek V, Schwarz RA, Williams MD, El-Naggar AK, Lee JJ, Gillenwater AM, Richards-Kortum R. Comparison of Multispectral Widefield Optical Imaging Modalities to Maximize Image Contrast for Objective Discrimination of Oral Neoplasia. J Biomed Opt 15(6):066017, 2010. e-Pub 2010. PMID: 21198191.
168. Moskovic DJ, Smolarz JR, Stanley D, Jimenez C, Williams MD, Hanna EY, Kupferman ME. Malignant head and neck paragangliomas: is there an optimal treatment strategy?. Head Neck Oncol 2:23, 2010. e-Pub 2010. PMID: 20863367.
169. McGovern SL, Williams MD, Weber RS, Sabichi A, Chambers MS, Martin JW, Chao KS. Three synchronous HPV-associated squamous cell carcinomas of Waldeyer's ring: case report and comparison with Slaughter's model of field cancerization. Head Neck 32(8):1118-24, 2010. e-Pub 2010. PMID: 19572386.
170. Cabanillas ME, Waguespack SG, Bronstein Y, Williams MD, Feng L, Hernandez M, Lopez A, Sherman SI, Busaidy NL. Treatment with tyrosine kinase inhibitors for patients with differentiated thyroid cancer: the M. D. Anderson experience. J Clin Endocrinol Metab 95(6):2588-95, 2010. e-Pub 2010. PMID: 20392874.
171. Williams MD, Esmaeli B, Soheili A, Simantov R, Gombos DS, Bedikian AY, Hwu P. GPNMB expression in uveal melanoma: a potential for targeted therapy. Melanoma Res 20(3):184-90, 2010. e-Pub 2010. PMID: 20375921.
172. Moreno MA, Roberts DB, Kupferman ME, DeMonte F, El-Naggar AK, Williams M, Rosenthal DS, Hanna EY. Mucosal Melanoma of the Nose and Paranasal Sinuses, a Contemporary Experience from the M. D. Anderson Cancer Center. Cancer 116(9):2215-23, 2010. e-Pub 2010. PMID: 20198705.
173. Williams MD, Roberts DB, Kies MS, Mao L, Weber RS, El-Naggar AK. Genetic and expression analysis of HER-2 and EGFR genes in salivary duct carcinoma: empirical and therapeutic significance. Clin Cancer Res 16(8):2266-74, 2010. e-Pub 2010. PMID: 20371674.
174. Weigum SE, Floriano PN, Redding SW, Yeh CK, Westbrook SD, McGuff HS, Lin A, Miller FR, Villarreal F, Rowan SD, Vigneswaran N, Williams MD, McDevitt JT. Nano-bio-chip Sensor Platform for Examination of Oral Exfoliative Cytology. Cancer Prev Res (Phila) 3(4):518-28, 2010. e-Pub 2010. PMID: 20332305.
175. Smolarz JR, Hanna EY, Williams MD, Kupferman ME. Paraganglioma of the endolarynx: a rare tumor in an uncommon location. Head Neck Oncol 2:2, 2010. e-Pub 2010. PMID: 20205783.
176. Shin D, Pierce MC, Gillenwater AM, Williams MD, Richards-Kortum RR. A Fiber-Optic Fluorescence Microscope Using a Consumer-Grade Digital Camera for In Vivo Cellular Imaging. PLoS One 5(6):e11218, 2010. e-Pub 2010. PMID: 20585636.
177. Schwarz RA, Gao W, Stepanek VM, Le TT, Bhattar VS, Williams MD, Wu JK, Vigneswaran N, Adler-Storthz K, Gillenwater AM, Richards-Kortum R. Prospective Evaluation of a Portable Depth-sensitive Optical Spectroscopy Device to Identify Oral Neoplasia. Biomed Opt Express 2(1):89-99, 2010. e-Pub 2010. PMID: 21326639.
178. Bell D, Kupferman ME, Williams MD, Rashid A, El-Naggar AK. Primary colonic-type adenocarcinoma of the base of the tongue: a previously unreported phenotype. Hum Pathol 40(12):1798-802, 2009. e-Pub 2009. PMID: 19695679.
179. Williams MD, Suliburk JW, Staerkel GA, Busaidy NL, Clayman GL, Evans DB, Perrier ND. Clinical Significance of Distinguishing between Follicular Lesion and Follicular Neoplasm in Thyroid Fine-needle Aspiration Biopsy. Ann Surg Oncol 16(11):3146-53, 2009. e-Pub 2009. PMID: 19727961.
180. Phan R, Phan L, Ginsberg LE, Blumenschein G, Williams MD, Esmaeli B. Durable response to chemotherapy for recurrent squamous cell carcinoma of the cheek with perineural spread. Arch Ophthalmol 127(8):1074-5, 2009. e-Pub 2009. PMID: 19667357.
181. Nitin N, Rosbach KJ, El-Naggar A, Williams M, Gillenwater A, Richards-Kortum RR. Optical molecular imaging of epidermal growth factor receptor expression to improve detection of oral neoplasia. Neoplasia 11(6):542-51, 2009. e-Pub 2009. PMID: 19484143.
182. Ahmad SM, Esmaeli B, Williams MD, Nguyen J, Fay A, Woog J, Selvadurai D, Rootman J, Weis E, Selva D, McNab A, DeAngelis D, Calle A, Lopez A. American Joint Committee on Cancer Classification Predicts Outcome of Patients with Lacrimal Gland Adenoid Cystic Carcinoma. Ophthalmology 116(6):1210-5, 2009. e-Pub 2009. PMID: 19395039.
183. Moeller BJ, Rana V, Cannon BA, Williams MD, Sturgis EM, Ginsberg LE, Macapinlac HA, Lee JJ, Ang KK, Chao KS, Chronowski GM, Frank SJ, Morrison WH, Rosenthal DI, Weber RS, Garden AS, Lippman SM, Schwartz DL. Prospective Risk-Adjusted [18F] Fluorodeoxyglucose Positron Emission Tomography and Computed Tomography Assessment of Radiation Response in Head and Neck Cancer. J Clin Oncol 27(15):2509-15, 2009. e-Pub 2009. PMID: 19332725.
184. Roblyer D, Kurachi C, Stepanek V, Williams MD, El-Naggar AK, Lee JJ, Gillenwater AM, Richards-Kortum R. Objective Detection and Delineation of Oral Neoplasia Using Autofluorescence Imaging. Cancer Prev Res (Phila) 2(5):423-31, 2009. e-Pub 2009. PMID: 19401530.
185. Waguespack SG, Sherman SI, Williams MD, Clayman GL, Herzog CE. The Successful Use of Sorafenib to Treat Pediatric Papillary Thyroid Carcinoma. Thyroid 19(4):407-12, 2009. e-Pub 2009. PMID: 19355831.
186. Cordes B, Williams MD, Tirado Y, Bell D, Rosenthal DI, Al-Dhahri SF, Hanna EY, El-Naggar AK. Molecular and phenotypic analysis of poorly differentiated sinonasal neoplasms: an integrated approach for early diagnosis and classification. Hum Pathol 40(3):283-92, 2009. e-Pub 2009. PMID: 19150107.
187. Jimenez C, Cabanillas ME, Santarpia L, Jonasch E, Kyle KL, Lano EA, Matin SF, Nunez RF, Perrier ND, Phan A, Rich TA, Shah B, Williams MD, Waguespack SG. Use of the tyrosine kinase inhibitor sunitinib in a patient with von Hippel-Lindau disease: targeting angiogenic factors in pheochromocytoma and other von Hippel-Lindau disease-related tumors. J Clin Endocrinol Metab 94(2):386-91, 2009. e-Pub 2009. PMID: 19017755.
188. Pavlova I, Weber CR, Schwarz RA, Williams MD, Gillenwater AM, Richards-Kortum R. Fluorescence spectroscopy of oral tissue: Monte Carlo modeling with site-specific tissue properties. J Biomed Opt 14(1):014009, 2009. e-Pub 2009. PMID: 19256697.
189. Henderson YC, Shellenberger TD, Williams MD, El-Naggar AK, Fredrick MJ, Cieply KM, Clayman GL. High Rate of BRAF and RET/PTC Dual Mutations Associated with Recurrent Papillary Thyroid Carcinoma. Clin Cancer Res 15(2):485-91, 2009. e-Pub 2009. PMID: 19147753.
190. Nitin N, Rosbach KJ, El-Naggar A, Williams MD, Gillenwater A, Richards-Kortum RR. Optical Molecular Imaging of Epidermal Growth Factor Receptor Expression to Improve Detection of Oral Neoplasia. Neoplasia 11(6):542-51, 2009. e-Pub 2009.
191. Pavlova I, Weber CR, Schwarz RA, Williams M, El-Naggar A, Gillenwater A, Richards-Kortum R. Monte Carlo model to describe depth selective fluorescence spectra of epithelial tissue: applications for diagnosis of oral precancer. J Biomed Opt 13(6):064012, 2008. e-Pub 2008. PMID: 19123659.
192. Chattopadhyay C, El-Naggar AK, Williams MD, Clayman GL. Small molecule c-MET inhibitor PHA665752: effect on cell growth and motility in papillary thyroid carcinoma. Head Neck 30(8):991-1000, 2008. e-Pub 2008. PMID: 18327775.
193. Thariat J, Ahamad A, El-Naggar AK, Williams MD, Holsinger FC, Glisson BS, Allen PK, Morrison WH, Weber RS, Ang KK, Garden AS. Outcomes after radiotherapy for basaloid squamous cell carcinoma of the head and neck: a case-control study. Cancer 112(12):2698-709, 2008. e-Pub 2008. PMID: 18429002.
194. Williams MD, Asa SL, Fuller GN. Medullary Thyroid Carcinoma Metastatic to the Pituitary Gland: An Unusual Site of Metastasis. Ann Diagn Pathol 12(3):199-203, 2008. e-Pub 2008. PMID: 18486896.
195. Mandal M, Myers JN, Lippman SM, Johnson FM, Williams MD, Rayala S, Ohshiro K, Rosenthal DI, Weber RS, Gallick GE, El-Naggar AK. Epithelial to mesenchymal transition in head and neck squamous carcinoma: association of Src activation with E-cadherin down-regulation, vimentin expression, and aggressive tumor features. Cancer 112(9):2088-100, 2008. e-Pub 2008. PMID: 18327819.
196. Lee ES, Issa JP, Roberts DB, Williams MD, Weber RS, Kies MS, El-Naggar AK. Quantitative promoter hypermethylation analysis of cancer-related genes in salivary gland carcinomas: comparison with methylation-specific PCR technique and clinical significance. Clin Cancer Res 14(9):2664-72, 2008. e-Pub 2008. PMID: 18451230.
197. Shellenberger TD, Williams MD, Clayman GL, Kumar AJ. Parotid Gland Oncocytosis: CT Findings with Histopathologic Correlation. AJNR Am J Neuroradiol 29(4):734-736, 2008. e-Pub 2008. PMID: 18272563.
198. Pavlova I, Williams MD, El-Naggar A, Richards-Kortum R, Gillenwater A. Understanding the biological basis of autofluorescence imaging for oral cancer detection: high-resolution fluorescence microscopy in viable tissue. Clin Cancer Res 14(8):2396-404, 2008. e-Pub 2008. PMID: 18413830.
199. Roblyer D, Richards-Kortum R, Sokolov K, El-Naggar AK, Williams MD, Kurachi C, Gillenwater AM. Multispectral Optical Imaging Device for In Vivo Detection of Oral Neoplasia. J Biomed Opt 13(2):024019, 2008. e-Pub 2008. PMID: 18465982.
200. Naqvi J, Ordonez NG, Luna MA, Williams MD, Weber RS, El-Naggar AK. Epithelioid hemangioendothelioma of the head and neck: role of podoplanin in the differential diagnosis. Head Neck Pathol 2(1):25-30, 2008. e-Pub 2008. PMID: 20614338.
201. Schwarz RA, Gao W, Daye D, Williams MD, Richards-Kortum R, Gillenwater AM. Autofluorescence and Diffuse Reflectance Spectroscopy of Oral Epithelial Tissue using a Depth-Sensitive Fiber-Optic Probe. Appl Opt 47(6):825-834, 2008. e-Pub 2008. PMID: 18288232.
202. Elliott DD, Sherman SI, Busaidy NL, Williams MD, Santarpia L, Clayman GL, El-Naggar AK. Growth factor receptors expression in anaplastic thyroid carcinoma: potential markers for therapeutic stratification. Hum Pathol 39(1):15-20, 2008. e-Pub 2008. PMID: 17949783.
203. Maitland KC, Gillenwater AM, Williams MD, El-Naggar AK, Descour MR, Richards-Kortums RR. In Vivo Imaging or Oral Neoplasia Using a Miniaturized Fiber Optic Confocal Reflectance Microscope. Oral Oncol 44(11):1059-66, 2008. e-Pub 2008. PMID: 19396445.
204. Lupinetti AD, Roberts DB, Williams MD, Kupferman ME, Rosenthal DI, Demonte F, El-Naggar A, Weber RS, Hanna EY. Sinonasal adenoid cystic carcinoma: the M. D. Anderson Cancer Center experience. Cancer 110(12):2726-31, 2007. e-Pub 2007. PMID: 17960615.
205. Muldoon TJ, Pierce MC, Nida DL, Williams MD, Gillenwater A, Richards-Kortum R. Subcellular-resolution molecular imaging within living tissue by fiber microendoscopy. Opt Express 15(25):16413-23, 2007. e-Pub 2007. PMID: 19550931.
206. Williams MD, Roberts D, Blumenschein GR Jr, Temam S, Kies MS, Rosenthal DI, Weber RS, El-Naggar AK. Differential expression of hormonal and growth factor receptors in salivary duct carcinomas: biologic significance and potential role in therapeutic stratification of patients. Am J Surg Pathol 31(11):1645-52, 2007. e-Pub 2007. PMID: 18059220.
207. Kantrow SM, Ivan D, Williams MD, Prieto VG, Lazar AJ. Metastasizing Adenocarcinoma and Multiple Neoplastic Proliferations Arising in a Nevus Sebaceous. Am J Dermatopathol 29(5):462-6, 2007. e-Pub 2007. PMID: 17890915.
208. Carlson AL, Gillenwater AM, Williams MD, El-Naggar AK, Richards-Kortum RR. Confocal Microscopy and Molecular-specific Optical Contrast Agents for the Detection of Oral Neoplasia. Technol Cancer Res Treat 6(5):361-374, 2007. e-Pub 2007. PMID: 17877424.
209. Tirado Y, Williams MD, Hanna EY, Kaye FJ, Batsakis JG, El-Naggar AK. CRTC1/MAML2 fusion transcript in high grade mucoepidermoid carcinomas of salivary and thyroid glands and Warthin's tumors: implications for histogenesis and biologic behavior. Genes Chromosomes Cancer 46(7):708-15, 2007. e-Pub 2007. PMID: 17437281.
210. Williams MD, Hanna EY, El-Naggar AK. Anaplastic Ameloblastic Fibrosarcoma Arising from Recurrent Ameloblastic Fibroma: Restricted Molecular Abnormalities of Certain Genes to the Malignant Transformation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 104(1):72-75, 2007. e-Pub 2007. PMID: 17577546.
211. Williams MD, Chakravarti N, Kies MS, Maruya S, Myers JN, Haviland JC, Weber RS, Lotan R, El-Naggar AK. Implications of Methylation Patterns of Cancer Genes in Salivary Gland Tumors. Clin Cancer Res 12(24):7353-7358, 2006. e-Pub 2006. PMID: 17189407.
212. Ohshiro K, Rayala SK, Williams MD, Kumar R, El-Naggar AK. Biological Role of Estrogen Receptor Beta in Salivary Gland Adenocarcinoma Cells. Clin Cancer Res 12(20 Pt 1):5994-5999, 2006. e-Pub 2006. PMID: 17062671.
213. Hsu ER, Gillenwater AM, Hasan MQ, Williams MD, El-Naggar AK, Richards-Kortum RR. Real-Time Detection of Epidermal Growth Factor Receptor Expression in Fresh Oral Cavity Biopsies Using a Molecular-Specific Contrast Agent. Int J Cancer 118(12):3062-3071, 2006. e-Pub 2006. PMID: 16395711.
214. Maruya S, Kies MS, Williams MD, Myers JN, Weber RS, Batsakis JG, El-Naggar AK. Differential Expression of p63 Isotypes (DeltaN and TA) in Salivary Gland Neoplasms: Biological and Diagnostic Implications. Hum Pathol 36(7):821-7, 2005. e-Pub 2005. PMID: 16084953.
215. Williams MD, Brown HM. The adequacy of gross pathological examination of routine tonsils and adenoids in patients 21 years old and younger. Hum Pathol 34(10):1053-7, 2003. e-Pub 2003. PMID: 14608541.
216. Williams MD, Antonelli PJ, Williams LS, Moorhead JE. Middle Ear Prosthesis Displacement in High Strength Magnetic Fields. Otol Neurotol 22(2):158-161, 2001. e-Pub 2001. PMID: 11300262.
217. Gillison M, Jiang X, Rudqvist NP, Jiang B, Ye S, He S, Liang Q, Dou J, Williams MD, Dunn J, Johnson J, Akagi K, Xiao W, Liang S, Elayavalli S, Sun B, Parra E, Ferrarotto R, Garden A, Fuller C, Reddy J, Gross N, Lango M, Hong Leung C, Liu S, Liu D, Lee J, Curran M, Phan J, Chen K. Depletion of effector regulatory T cells drives major response to induction dual immune checkpoint blockade. Nature Cancer.
218. Cabanillas M, Dadu R, Ferrarotto R, Gule-Monroe M, Liu S, Fellman B, Williams MD, Zafereo M, Wang J, Lu C, Ning M, McKinley B, Woodman S, Duose D, Gunn G, Busaidy N. Anti-PD-L1 plus targeted therapy in Anaplastic Thyroid Carcinoma. JAMA Oncol.

Invited Articles

1. Yaniv D, Seiwert TY, Margalit DN, Williams MD, Barbon CEA, Largo RD, Smith JA, Gross ND. Neoadjuvant chemotherapy for advanced oral cavity cancer. CA Cancer J Clin 74(3):213-223, 2024. e-Pub 2024. PMID: 38329372.
2. Lowenstein LM, Basourakos SP, Williams MD, Troncoso P, Gregg JR, Thompson TC, Kim J. Active surveillance for prostate and thyroid cancers: evolution in clinical paradigms and lessons learned. Nat Rev Clin Oncol 16(3):168-184, 2019. e-Pub 2019. PMID: 30413793.
3. Sabharwal A, Magliocca KR, Williams MD. Ear and Temporal Bone: Cartilaginous and Osseous Pathologies. Head Neck Pathol 12(3):378-391, 2018. e-Pub 2018. PMID: 30069840.
4. Williams MD. Determining Adequate Margins in Head and Neck Cancers: Practice and Continued Challenges. Curr Oncol Rep 18(9):54, 2016. e-Pub 2016. PMID: 27469263.
5. Cabanillas ME, Dadu R, Hu MI, Lu C, Gunn GB, Grubbs EG, Lai SY, Williams MD. Thyroid Gland Malignancies. Hematol Oncol Clin North Am 29(6):1123-43, 2015. e-Pub 2015. PMID: 26568552.
6. Woodman SE, Williams MD, Esmaeli B. Uveal Melanoma: Molecular Basis and Potential Treatment Targets. US Ophthalmic Review 4(2):131-5, 2011. e-Pub 2011.
7. McDevitt J, Weigum SE, Floriano PN, Christodoulides N, Redding SW, Yeh CK, McGuff S, Vigneswaran N, Thornhill MH, Williams MD. A New Bio-nanochip Sensor Aids Oral Cancer Detection. SPIE Newsroom, 2011. e-Pub 2011. PMID: 21818462.
8. Williams MD. Integration of Biomarkers Including Molecular Targeted Therapies in Head and Neck Cancer. Head Neck Pathol 4(1):62-9, 2010. e-Pub 2010. PMID: 20237991.
9. Grubbs EG, Rich TA, Li G, Sturgis EM, Younes MN, Myers JN, Edeiken-Monroe B, Fornage BD, Monroe DP, Staerkel GA, Williams MD, Waguespack SG, Hu MI, Cote G, Gagel RF, Cohen J, Weber RS, Anaya DA, Holsinger FC, Perrier ND, Clayman GL, Evans DB. Recent Advances in Thyroid Cancer. Curr Probl Surg 45(3):156-250, 2008. e-Pub 2008. PMID: 18346477.

Review Articles

1. Hamidi, S, Maniakas, A, Akhave, NS, Banuchi, VE, Busaidy, NL, Dadu, R, Ferrarotto, R, Guise, TA, Hofmann, M, Hosseini, SM, Hu, MI, Iyer, PC, Mansour, M, Marczyk, VR, Roy Chowdhuri, S, Sherman, SI, Sousa, LG, Wang, RJ, Williams, MD, Zafereo, M, Waguespack, SG, Cabanillas, ME. Characterization of Advanced RAS-driven Follicular-derived Thyroid Cancers and Review of Future Therapeutic Avenues. Journal of Clinical Endocrinology and Metabolism 111(2):471-483, 2026. e-Pub 2026. PMID: 40568752.
2. Dok, R, Nuyts, S, Lopez, F, Bradford, CR, Forastiere, AA, Strojan, P, Agaimy, A, Stenman, G, Mariano, FV, Leivo, I, Rao, KN, Williams, MD, Eisbruch, A, Saba, NF, Ferlito, A. The Value of Circulating Tumor HPV DNA in Head and Neck Squamous Cell Cancer. Diagnostics 15(21), 2025. e-Pub 2025. PMID: 41226001.
3. Naara S, Andrews C, Sikora A, Williams M, Chambers M, Myers J, Amit M. Oral Pre-malignancy: An Update on Novel Therapeutic Approaches. Curr Oncol Rep 26(9):1047-1056, 2024. e-Pub 2024. PMID: 38865005.
4. Bradley PJ, Stenman G, Thompson LDR, Skálová A, Simpson RHW, Slootweg PJ, Franchi A, Zidar N, Nadal A, Hellquist H, Williams MD, Leivo I, Agaimy A, Ferlito A. Metastatic cutaneous squamous cell carcinoma accounts for nearly all squamous cell carcinomas of the parotid gland. Virchows Arch 485(1):3-11, 2024. e-Pub 2024. PMID: 38630141.
5. Coca-Pelaz A, Rodrigo JP, Agaimy A, Williams MD, Saba NF, Nuyts S, Randolph GW, López F, Vander Poorten V, Kowalski LP, Civantos FJ, Zafereo ME, Mäkitie AA, Cohen O, Nixon IJ, Rinaldo A, Ferlito A. Poorly differentiated thyroid carcinomas: conceptual controversy and clinical impact. Virchows Arch 484(5):733-742, 2024. e-Pub 2024. PMID: 38400843.
6. Ramesh U, Contrera KJ, Shakibai N, Su SY, Brahimaj B, Roberts D, Williams MD, Ferrarotto R, Phan J, Gunn GB, Raza S, DeMonte F, Hanna EY. Sinonasal NUT carcinoma: A consecutive case series and systematic review. Head Neck 46(1):29-36, 2024. e-Pub 2024. PMID: 37853958.
7. Haddad R, Elisei R, Hoff AO, Liu Z, Pitoia F, Pruneri G, Sadow PM, Soares F, Turk A, Williams MD, Wirth LJ, Cabanillas ME. Diagnosis and Management of Tropomyosin Receptor Kinase Fusion-Positive Thyroid Carcinomas: A Review. JAMA Oncol 9(8):1132-1141, 2023. e-Pub 2023. PMID: 37289450.
8. Coca-Pelaz A, Rodrigo JP, Lopez F, Shah JP, Silver CE, Al Ghuzlan A, Menke-van der Houven van Oordt CW, Smallridge RC, Shaha AR, Angelos P, Mendenhall WM, Piazza C, Olsen KD, Corry J, Tufano RP, Sanabria A, Nuyts S, Nathan CA, Vander Poorten V, Dias FL, Suarez C, Saba NF, de Graaf P, Williams MD, Rinaldo A, Ferlito A. Evaluating new treatments for anaplastic thyroid cancer. Expert Rev Anticancer Ther 22(11):1239-1247, 2022. e-Pub 2022. PMID: 36283091.
9. Fernandez Branson C, Williams MD, Chan TM, Graber ML, Lane KP, Grieser S, Landis-Lewis Z, Cooke J, Upadhyay DK, Mondoux S, Singh H, Zwaan L, Friedman C, Olson APJ. Improving diagnostic performance through feedback: the Diagnosis Learning Cycle. BMJ Qual Saf 30(12):1002-1009, 2021. e-Pub 2021. PMID: 34417335.
10. Williams MD. Preoperative Molecular Testing of Thyroid Nodules: Current Concepts. Neuroimaging Clin N Am 31(3):301-312, 2021. e-Pub 2021. PMID: 34243865.
11. Franchi A, Thompson LDR, Hernandez-Prera JC, Agaimy A, Williams MD, Mikkelsen LH, Bishop JA, Willems SM, Hellquist H, Ferlito A. Emerging Entities and New Diagnostic Markers for Head and Neck Soft Tissue and Bone Tumors. Adv Anat Pathol 28(3):139-149, 2021. e-Pub 2021. PMID: 33559990.
12. Rodrigo JP, Sánchez-Canteli M, López F, Wolf GT, Hernández-Prera JC, Williams MD, Willems SM, Franchi A, Coca-Pelaz A, Ferlito A. Tumor-Infiltrating Lymphocytes in the Tumor Microenvironment of Laryngeal Squamous Cell Carcinoma: Systematic Review and Meta-Analysis. Biomedicines 9(5), 2021. e-Pub 2021. PMID: 33925205.
13. Williams MD, Franchi A, Helliwell T, Muller S, Thompson LDR. Data Set for the Reporting of Mucosal Melanomas of the Head and Neck: Explanations and Recommendations of the Guidelines From the International Collaboration on Cancer Reporting. Arch Pathol Lab Med 143(5):603-609, 2019. e-Pub 2019. PMID: 30500297.
14. Bullock MJ, Beitler JJ, Carlson DL, Fonseca I, Hunt JL, Katabi N, Sloan P, Taylor SM, Williams MD, Thompson LDR. Data Set for the Reporting of Nodal Excisions and Neck Dissection Specimens for Head and Neck Tumors: Explanations and Recommendations of the Guidelines From the International Collaboration on Cancer Reporting. Arch Pathol Lab Med 143(4):452-462, 2019. e-Pub 2019. PMID: 30500291.
15. Thomas Robbins K, Triantafyllou A, Suárez C, López F, Hunt JL, Strojan P, Williams MD, Braakhuis BJM, de Bree R, Hinni ML, Kowalski LP, Rinaldo A, Rodrigo JP, Vander Poorten V, Nixon IJ, Takes RP, Silver CE, Ferlito A. Surgical margins in head and neck cancer: Intra- and postoperative considerations. Auris Nasus Larynx 46(1):10-17, 2019. e-Pub 2019. PMID: 30172560.
16. Andreasen S, Bishop JA, Hellquist H, Hunt J, Kiss K, Rinaldo A, Skálová A, Willems SM, Williams MD, Ferlito A. Biphenotypic sinonasal sarcoma: demographics, clinicopathological characteristics, molecular features, and prognosis of a recently described entity. Virchows Arch 473(5):615-626, 2018. e-Pub 2018. PMID: 30109475.
17. Lopez F, Hunt JL, Nixon IJ, Rinaldo A, Williams MD, Cardesa A, Ferlito A. How phenotype guides management of the neuroendocrine carcinomas of the larynx. J Laryngol Otol 132(7):568-574, 2018. e-Pub 2018. PMID: 29909787.
18. D'Cruz AK, Vaish R, Vaidya A, Nixon IJ, Williams MD, Vander Poorten V, López F, Angelos P, Shaha AR, Khafif A, Skalova A, Rinaldo A, Hunt JL, Ferlito A. Molecular markers in well-differentiated thyroid cancer. Eur Arch Otorhinolaryngol 275(6):1375-1384, 2018. e-Pub 2018. PMID: 29626249.
19. Mendenhall WM, Suárez C, Skálová A, Strojan P, Triantafyllou A, Devaney KO, Williams MD, Rinaldo A, Ferlito A. Current Treatment of Endolymphatic Sac Tumor of the Temporal Bone. Adv Ther. e-Pub 2018. PMID: 29923043.
20. Nixon IJ, Angelos P, Shaha AR, Rinaldo A, Williams MD, Ferlito A. Image-guided chemical and thermal ablations for thyroid disease: Review of efficacy and complications. Head Neck. e-Pub 2018. PMID: 29684251.
21. Sanabria A, Kowalski LP, Shah JP, Nixon IJ, Angelos P, Williams MD, Rinaldo A, Ferlito A. Growing incidence of thyroid carcinoma in recent years: Factors underlying overdiagnosis. Head Neck 40(4):855-866, 2018. e-Pub 2018. PMID: 29206325.
22. Cabanillas ME, Zafereo M, Williams MD, Ferrarotto R, Dadu R, Gross N, Gunn GB, Skinner H, Cote G, Grosu HB, Iyer P, Busaidy NL. Recent advances and emerging therapies in anaplastic thyroid carcinoma. F1000Res 7, 2018. e-Pub 2018. PMID: 31583077.
23. Williams MD. Paragangliomas of the Head and Neck: An Overview from Diagnosis to Genetics. Head Neck Pathol 11(3):278-287, 2017. e-Pub 2017. PMID: 28321772.
24. López F, Williams MD, Cardesa A, Hunt JL, Strojan P, Rinaldo A, Nixon IJ, Rodrigo JP, Saba NF, Mendenhall WM, Quer M, Suárez C, Ferlito A. How phenotype guides management of non-conventional squamous cell carcinomas of the larynx?. Eur Arch Otorhinolaryngol 274(7):2709-2726, 2017. e-Pub 2017. PMID: 28364287.
25. Cabanillas ME, Williams MD, Gunn GB, Weitzman SP, Burke L, Busaidy NL, Ying AK, Yiin YH, William WN, Lu C, Lai SY. Facilitating anaplastic thyroid cancer specialized treatment: A model for improving access to multidisciplinary care for patients with anaplastic thyroid cancer. Head Neck 39(7):1291-1295, 2017. e-Pub 2017. PMID: 28452157.
26. López F, Williams MD, Skálová A, Hellquist H, Suárez C, Nixon IJ, Rodrigo JP, Cardesa A, Strojan P, Quer M, Hunt JL, Rinaldo A, Ferlito A. How Phenotype Guides Management of the Most Common Malignant Salivary Neoplasms of the Larynx?. Adv Ther 34(4):813-825, 2017. e-Pub 2017. PMID: 28224460.
27. Suárez C, Barnes L, Silver CE, Rodrigo JP, Shah JP, Triantafyllou A, Rinaldo A, Cardesa A, Pitman KT, Kowalski LP, Robbins KT, Hellquist H, Medina JE, de Bree R, Takes RP, Coca-Pelaz A, Bradley PJ, Gnepp DR, Teymoortash A, Strojan P, Mendenhall WM, Eloy JA, Bishop JA, Devaney KO, Thompson LD, Hamoir M, Slootweg PJ, Vander Poorten V, Williams MD, Wenig BM, Skálová A, Ferlito A. Cervical lymph node metastasis in adenoid cystic carcinoma of oral cavity and oropharynx: A collective international review. Auris Nasus Larynx 43(5):477-84, 2016. e-Pub 2016. PMID: 27017314.
28. Coca-Pelaz A, Barnes L, Rinaldo A, Cardesa A, Shah JP, Rodrigo JP, Suárez C, Eloy JA, Bishop JA, Devaney KO, Thompson LD, Wenig BM, Strojan P, Hamoir M, Bradley PJ, Gnepp DR, Silver CE, Slootweg PJ, Triantafyllou A, Vander Poorten V, Williams MD, Skálová A, Hellquist H, Teymoortash A, Medina JE, Robbins KT, Pitman KT, Kowalski LP, de Bree R, Mendenhall WM, Takes RP, Ferlito A. Cervical Lymph Node Metastasis in Adenoid Cystic Carcinoma of the Larynx: A Collective International Review. Adv Ther 33(4):553-79, 2016. e-Pub 2016. PMID: 27084720.
29. Chattopadhyay C, Kim DW, Gombos DS, Oba J, Qin Y, Williams MD, Esmaeli B, Grimm EA, Wargo JA, Woodman SE, Patel SP. Uveal Melanoma: From Diagnosis to Treatment and the Science in Between. Cancer. e-Pub 2016. PMID: 26991400.
30. Ferlito A, Rinaldo A, Bishop JA, Hunt JL, Vander Poorten V, Williams MD, Triantafyllou A, Devaney KO, Gnepp DR, Kusafuka K, Halmos GB, Westra WH, Takes RP, Thompson LD. Paraneoplastic syndromes in patients with laryngeal neuroendocrine carcinomas: clinical manifestations and prognostic significance. Eur Arch Otorhinolaryngol 273(3):533-6, 2016. e-Pub 2016. PMID: 25351497.
31. Hellquist H, Skalova A, Barnes L, Cardesa A, Thompson LD, Triantafyllou A, Williams MD, Devaney KO, Gnepp DR, Bishop JA, Wenig BM, Suarez C, Rodrigo JP, Coca-Pelaz A, Strojan P, Shah JP, Hamoir M, Bradley PJ, Silver CE, Slootweg PJ, Vander Poorten V, Teymoortash A, Medina JE, Robbins KT, Pitman KT, Kowalski LP, de Bree R, Mendenhall WM, Eloy JA, Takes RP, Rinaldo A, Ferlito A. Cervical Lymph Node Metastasis in High-Grade Transformation of Head and Neck Adenoid Cystic Carcinoma: A Collective International Review. Adv Ther 33(3):357-68, 2016. e-Pub 2016. PMID: 26895332.
32. Williams MD, Rich TA. Paragangliomas Arising in the Head and Neck: A Morphologic Review and Genetic Update. Surg Pathol Clin 7(4):543-57, 2014. e-Pub 2014. PMID: 26837554.
33. Rich TA, Michelle D Williams MD. Paragangliomas Arising in the Head and Neck: A Morphologic review and genetic update Reference. Surgical Pathology Clinics 7(4):543-557, 2014. e-Pub 2014. PMID: 28247224.
34. Lewis JS Jr, Westra WH, Thompson LD, Barnes L, Cardesa A, Hunt JL, Williams MD, Slootweg PJ, Triantafyllou A, Woolgar JA, Devaney KO, Rinaldo A, Ferlito A. The sinonasal tract: another potential "hot spot" for carcinomas with transcriptionally-active human papillomavirus. Head Neck Pathol 8(3):241-9, 2014. e-Pub 2014. PMID: 24338611.
35. Rodrigo JP, Garcia-Pedrero JM, Suarez C, Takes RP, Thompson LD, Slootweg PJ, Woolgar JA, Westra WH, Brakenhoff RH, Rinaldo A, Devaney KO, Williams MD, Gnepp DR, Ferlito A. Biomarkers predicting malignant progression of laryngeal epithelial precursor lesions: a systematic review. Eur Arch Otorhinolaryngol 269(4):1073-83, 2012. e-Pub 2012. PMID: 22081098.

Professional Educational Materials

1. Subbiah V, Drilon A, Williams MD. Incorporating genomic profiling into the standard-of care for NSCLC and thyroid cancer. Springer Healthcare Education.

Other Articles

1. Marczyk, VR, Fazeli, S, Dadu, R, Busaidy, NL, Iyer, PC, Hu, MI, Sherman, SI, Hamidi, S, Hosseini, SM, Williams, MD, Ahmed, S, Routbort, MJ, Luthra, R, Roy Chowdhuri, S, San Lucas, FA, Patel, KP, Hong, DS, Zafereo, M, Wang, RJ, Maniakas, A, Waguespack, SG, Cabanillas, ME Erratum. JCO Precision Oncology 9, 2025. PMID: 40632979.
2. Pan J, Mai H, Ng WT, Hu C, Li J, Chen X, H Chow JC, Wong E, Lee V, Ma L, Guo Q, Liu Q, Liu L, Xu T, Gong X, Qiang M, Au K, Liu T, Chiang CL, Xiao Y, Lin S, Chen Y, Guo S, L Wong CH, Tang L, Xu Z, Jia Y, Peng W, Hu L, Lu T, Jiang F, Cao C, Xu W, Ma J, Blanchard P, Williams M, Glastonbury CM, King AD, Patel SG, Seethala RR, Colevas A, Fan D, K Chua ML, Huang SH, O’Sullivan B, Lydiatt W, M Lee AW The AJCC and UICC Ninth Version of the Nasopharyngeal Cancer TNM Staging Classification. JAMA Oncol.
3. Vander Poorten V, Goedseels N, Triantafyllou A, Sanabria A, Clement PM, Cohen O, Golusinski P, Guntinas-Lichius O, Piazza C, Randolph GW, Rinaldo A, Ronen O, Cabanillas ME, Shaha AR, Teng Y, Tufano RP, Williams MD, Zafereo M, Ferlito A Effectiveness of core needle biopsy in the diagnosis of thyroid lymphoma and anaplastic thyroid carcinoma: A systematic review and meta-analysis. Front Endocrinol (Lausanne) 13:971249, 2022. PMID: 36204100.

Editorials

1. Magliocca KR, Williams MD. Introduction to Ear and Temporal Bone Special Issue. Head Neck Pathol 12(3):301, 2018. PMID: 30069847.
2. Shaha AR, Silver CE, Angelos P, Nixon IJ, Rodrigo JP, Sanabria A, Vander Poorten V, Williams MD, Rinaldo A, Ferlito A. The central compartment - Center of controversy, confusion, and concern in management of differentiated thyroid cancer. Eur J Surg Oncol 43(11):1981-1984, 2017. PMID: 28916416.

Abstracts

1. Naara S, Yaniv D, Andrews C, Sathishkumar H, Guimaraes de Sousa L, Akhave N, Williams M, Myers J, Chambers M, Amit M. Intralesional nivolumab in oral potentially malignant disorders: A phase 1 pilot study on safety, tolerability, and preliminary efficacy 42(16), 2024. e-Pub 2024.
2. Hamidi S, Dadu R, Busaidy N, Ferrarotto R, Gule-Monroe M, Liu S, Fellman B, Williams M, Zafereo M, Wang R, Lu C, Ning M, McKinley B, Woodman S, Duose D, Cabaniilas M, Gunn G. Cobimetinib plus atezolizumab for RAS and NF1/2-mutated poorly differentiated thyroid carcinoma 42(16), 2024. e-Pub 2024.
3. Salem A, Chen M, McQuade J, Amaria R, Swanson D, Williams MD, Farooqi A, Bishop A, Hanna E, Guadagnolo A, Su S, Mitra D. Sinonasal Melanoma Outcomes after Neoadjuvant Immunotherapy. American Society for Radiation Oncology, 2024. e-Pub 2024.
4. Allen D, Hosseini M, Ratan R, Nair R, Lu C, Patel S, Ravi V, Halperin D, Busaidy N, Iyer P, Grubbs E, Diaz E, Lango M, Wang R, Zafereo M, Williams M, Cabanillas M, Maniakas A. Unusual Thyroid Pathologies: Presentation, Management, and Clinical Outcomes. Thyroid 33(S1):P-1-A-185, 2023. e-Pub 2023.
5. Contrera KJ, Ferrarotto R, Gunn B, Su SY, Glisson BS, Garden AS, Roberts D, El-Naggar A, Williams MD, Raza S, DeMonte F, Chen MM, Chambers M, Hanna EY. Phase II Trial of Induction Chemotherapy for Advanced Sinonasal Squamous Cell or Poorly Differentiated Carcinoma. JCO 41(16 suppl), 2023. e-Pub 2023.
6. Williams MD. Role of the programmed death-ligand 1 (PD-L1) and antigen presenting natural Killer (AP-NK) cells in immunosuppressive tumor microenvironment (TME) of oral squamous cell carcinomas. 2023 AAOMP Meeting, 2023. e-Pub 2023.
7. Contrera K, Ferrarotto R, Gunn G, Su S, Kies M, Glisson B, Garden A, Roberts D, El-Naggar A, Wiilliams M, Raza S, DeMonte F, Chen M, Chambers M, Hanna E. Phase II prospective trial of induction chemotherapy for advanced sinonasal squamous cell or poorly differentiated carcinoma 41(16_suupl):6090, 2023. e-Pub 2023.
8. Cabanillas M, Busaidy N, Zafereo M, Gule-Monroe M, Liu S, Ferrarotto R, Lu C, Gross N, Fellman B, Brosu H, Williams M, Iyer P, Maniakas A, Wang J, Dadu R. BRAF/MEK Inhibitor Plus Immunotherapy for BRAFV600E-mutated Anaplastic Thyroid Carcinoma. Thyroid 32(S1), 2022. e-Pub 2022.
9. Fazeli S, Hofmann MC, Gule-Monroe M, McBeath E, Cabanillas M, Busaidy N, Waguespack S, Hu M, Jimenez C, Sherman S, Habra M, Cote G, Bassett R, Williams M, Dadu R. BRAF +/- MEK inhibitor therapy in BRAF V600E-mutated differentiated thyroid carcinoma: Does the presence of a TERT promoter mutation influence therapeutic response?. Thyroid 32(S1), 2022. e-Pub 2022.
10. Williams MD, Pelekanou V, Hoehne J, de Zoete J, Schmitz, Bal T, Banerji T, Gerrer JJ, Bernar-Gauthier V, Rudolph M, Theron M, Cabanilla M, Lenda M, di Tomaso E. Deep Learning Identified Oncogenic Genetic Alterations in BRAF and NTRK in H&E Whole Slide IMages from Thyroid Carcinomas. Annuals of Oncology 33(Supplement 7):S1296, 2022. e-Pub 2022.
11. Vodopivec D, Cabanillas M, Busaidy N, Gule-Monroe M, Zafereo M, Wang J, Williams M, Waguespack S, Bassett R, Maniakas A, Lai S, Dadu R. Single Center Experience with the Combination of Lenvatinib and Pembrolizumab for the Treatment of Anaplastic Thyroid Cancer. Journal Of Endocrine Society 6(Supplement_1):A848-49, 2022. e-Pub 2022.
12. Pelekanou V, Hohne J, de Zoete J, Schmitz A, Bal T, Ferrer J, Bernard-Gauthier V, Rudolph M, Theron M, Cabanillas M, Williams MD, Lenga M, di Tomaso E. Deep Learning Identifies Oncogenic Genetic Alterations in BRAF and NTRK in H&E Whole Slide Images from Thyroid Carcinomas. Thyroid 32(S1), 2022. e-Pub 2022.
13. Williams M. Single-cell tumor-infiltrating T cell landscape and dynamics in human papillomavirus positive oropharyngeal squamous cell carcinoma before and during CTLA-4 and PD-1 immune checkpoint blockade. 2022 SITC 37th Annual Meeting & Pre-Conference Programs, 2022. e-Pub 2022.
14. Gillison M, Williams MD, Johnson J, Leung C, Reddy J, Garden A, Ferrarotto R, Mott F, Le X, Gunn G, Lee A, Fuller C, Lu C, Moreno A, Hutcheson K, Gross N, Lango M, Goepfert R, Myers J, Hanna E, Xiao W, Jiang B, Rudqvist NP, Lee J, Phan J. Phase 2 trial of induction and concomitant CTLA4 (ipilimumab) and PD-1 (nivolumab) immune checkpoint blockade and intensity modulated radiation therapy (IMRT) in HPV-positive oropharyngeal squamous cell carcinoma (HPV-OPSCC). J Immunother Cancer 10(Suppl 2):A594-95, 2022. e-Pub 2022.
15. Gonzalez H, Zafereo M, Vargas S, et al. Thyroidprint Accurately Predicts Benign Nodules with Indeterminate Cytology: An International Multi-Center Study. Latin American Thyroid Society, 2019. e-Pub 2019.
16. Liang L, Williams MD, Bell D. The Expression of PTEN, androgen receptor, HER2, cytokeratin 5/6, estrogen receptor-beta, HMGA2 and PLAG1 in Salivary Duct Carcinoma, 2018. e-Pub 2018.
17. Dadu R, Vilalabos PA, Para Cuentas ER, Rodriguez Canales J, Wistuba II, Zhou S, Williams MD, Cabanillas M. Anaplastic Thyroid Cancer (ATC) is a Hot Immunogenic Environment: Immunoprofiling of a Large Cohort of ATC Tumors 26, 2016. e-Pub 2016.
18. Sandulache V, Williams MD, Lai SY, LuC, William WN, Busaidy NL, Cabanillas ME. Clinical genomic testing of anaplastic thyroid carcinoma (ATC) and need for integration into future prospective clinical trials 34, 2016. e-Pub 2016.
19. Schwarz R, Pierce M, Bhattar V, Mondrick S, Williams MD, Richards-Kortum R, Gillenwater A. Non-invasive identification of oral dysplasia with multi-modal optical imaging, 2012. e-Pub 2012.
20. Gillenwater A, Schwarz RA, Bhattar V, Dhar S, Merry J, Mondrik S, Pierce M, Gao W, Williams MD, Vigneswaran N, Richards-Kortum R. Applications of Autofluorescence Imaging and Spectroscopy for Oral Cancer Surveillance (#163958), 2012. e-Pub 2012.
21. Schwarz RA, Pierce MC, Bhattar V, Mondrik S, Williams MD, Gillenwater AM, Richards-Kortum R. Multimodal optical imaging for detection of oral neoplasia, 2012. e-Pub 2012.
22. Schwarz RA, Pierce MC, Bhattar V, Mondrik S, Williams MD, Gillenwater AM, Richards-Kortum R. Multimodal optical imaging for detection of oral neoplasia (#3566), 2012. e-Pub 2012.
23. Schwarz RA, Pierce MC, Mondrik S, Gao W, Quinn MK, Bhattar VS, Williams MD, Vigneswaran N, Gillenwater AM, Richards-Kortum RR. Longitudinal evaluation of patients with oral potentially malignant disorders using optical imaging and spectroscopy(#8207C-51), 2012. e-Pub 2012.
24. Williams MD, Cabanillas ME, Clayman GL. Epidermal Growth Factor Receptor Over-expression in Thyroid Neoplasia Associates with Chromosome 7 Polysomy 23:589A, 2010. e-Pub 2010.
25. Cabanillas ME, Waguespack SG, Bronstein Y, Williams MD, Feng L, Sherman SI, Busaidy NL. Treatment with tyrosine kinase inhibitors for patients with differentiated thyroid cancer: The M. D. Anderson Cancer Center experience 27(15s), 2009. e-Pub 2009.
26. Williams MD, Luna MA, Busaidy NL, Clayman GL. Platelet Derived Growth Factor Receptor Beta (PDGFRβ) is Widely Expressed in Thyroid Neoplasms of Both C-Cell and Follicular Origin 22:539, 2009. e-Pub 2009.
27. Cordes B, MD W, Bell D, Hanna EY, El-Naggar AK. Molecular and Phenotypic Analysis of Undifferentiated Skull Base and Paranasal Sinuses Neoplasms: An Integrated Approach to Diagnosis and Classification 21:233A, 2008. e-Pub 2008.
28. Williams MD, Issa JP, Lu C, Clayman GL, El-Naggar AK. Methylation Screening of Thyroid Cell Lines and Tissues 21:111A, 2008. e-Pub 2008.
29. Williams MD, Kies MS, Weber RS, El-Naggar AK. Expression of Epidermal Growth Factor Family of Receptors in Salivary Duct Carcinomas: Comparative Methods and Targeted Therapy 21:243A, 2008. e-Pub 2008.
30. Williams MD, Suliburk JW, Staerkel GQ, Busaidy NL, Lee JE, Clayman GL, Evans DB, Perrier ND. The Incidence of Occult Papillary Thyroid Carcinomas in Patients with Benign Thyroid Nodules 21:111A, 2008. e-Pub 2008.
31. Poindexter N, Esmaeli B, Hatef E, Gombos D, Fuller G, Williams MD, Grimm E. Expression of the Immunosuppressive marker B7-H1 in Uveal Melanoma. International Congress of Ocular Oncology, 2007. e-Pub 2007.
32. Waguespack SG, Williams MD, Clayman GL, Herzog CE. First Successful Use of Sorafenib to Treat Pediatric Thyroid Carcinoma. Pediatric Academic Societies Annual Meeting, 2007. e-Pub 2007.
33. Williams MD, Mandal M, Myers JN, Weer RS, Gallick G, El-Naggar AK. Epithelial-Mesenchymal Transformation and Invasion in Head and Neck Squamous Carcinoma 20:225A, 2007. e-Pub 2007.
34. Naqvi JF, Ordonez NG, Williams MD, El-Naggar AK. Epithelioid Hemangioendothelioma of the Head and Neck: A Clinicopathologic and Immunohistochemical Study 20:227A, 2007. e-Pub 2007.
35. Lee ES, Williams MD, Haviland JC, El-Naggar AK. DNA Methylation: A Comparative Study of Methodologies in Salivary Gland Neoplasia 20:231A, 2007. e-Pub 2007.
36. Kantrow S, Ivan D, Prieto VG, Williams MD, Lazar AJF. Adenocarcinoma with Multiple Differentiation Lines Arising in a Nevus Sebaceous. American Society of Dermatopathology Annual Meeting, 2006. e-Pub 2006.
37. Williams MD, Kies MS, Luna MA, El-Naggar AK. Hormonal Profiling in Salivary Duct Carcinoma: Potential Stratification for Therapy 19:212A-213A, 2006. e-Pub 2006.
38. Williams MD, Luna MA, El-Naggar AK. Basaloid Salivary Gland Neoplasms: Imbalance of the Apoptotic/Proliferative Homeostasis in Pathogenesis 19:213A, 2006. e-Pub 2006.
39. Williams MD, Ohshiro K, Elliott D, Luna MA, El-Naggar AK. Differential Role of p63 Gene Isotypes in Head and Neck Squamous Tumorigenesis 19:212A, 2006. e-Pub 2006.
40. Williams MD, Maruya SI, Luna MA, Elliott D, Batsakis JG, El-Naggar AK. Differential Expression of p63 Isotypes in Salivary Gland Tumorgenesis: Histogenetic and Biologic Relevance 18:219A, 2005. e-Pub 2005.
41. Williams MD, Vadlamudi RK, Sahin AA, Kies MS, Kumar R, El-Naggar AK. Novel Estrogen Receptor Coactivator PELP1/MNAR Gene and ERbeta Expressed in Salivary Duct Adenocarcinoma: Potential Therapeutic Targets 18:218A-219A, 2005. e-Pub 2005.
42. Williams MD, Mazzaferri EL, Massoll NA. The Characteristics of Colloid: Malignant Versus Benign Entities in Thyroid Fine Needle Aspirations 16:85A-86A, 2003. e-Pub 2003.
43. Williams MD, Brown HM. The Adequacy of Gross Examination of Routine Tonsils and Adenoids in Patients 21 Years and Younger 15:226A, 2002. e-Pub 2002.
44. Thennavan A, Tarabichi M, Zafereo M, Williams MD, Wu CC, Martin M, Tran T, Lai S, Cabanillas M, Iyer P, Maniakas A, Henderson Y, Zhao X, Busaidy N, Dadu R, Navin N, Wang J. BRAF treatment response determinants in Anaplastic Thyroid Cancer studied through single cell DNA and RNA sequencing.
45. Williams MD. Neoadjuvant pembrolizumab in combination with dabrafenib and trametinib (DTP) for BRAF V600E-mutated anaplastic thyroid cancer (BRAFm-ATC): A multicenter phase 2 trial. 2025 ASCO Annual Meeting.
46. Diaz HG, Zafereo M, Vederrabano P, Tufano R, Kowalski L, Simo R, Maruti S, Golbert L, Maniakas A, Wang J, Busaidy N, Williams MD, Luengo P, Gomez J, Pian H, Ruz I, Sune V, Gonzales V, Dominguez JM. New sample-to-result Idylla-ThyroidPrint Assay accurately identifies benign thyroid nodules with indeterminate cytology: A multicenterprospective double-blinded clinical validation trial. European Thyroid Association.

Book Chapters

1. Choisea S, Di Palma S, Thompson LDR, Weinreb I, Williams MD. Intercalated duct adenoma and hyperplasia. In: Head and Neck Tumours WHO Classification of Tumours. 5th Edition. International Agency for Research on Cancer, 192-193, 2024.
2. Gnepp DR, Di Palma S, Thompson, LDR, Weinreb I, Williams MD. Sebaceous adenoma. In: Head and Neck Tumours WHO Classification of Tumours. 5th Edition. International Agency for Research on Cancer, 190-191, 2024.
3. Prasad ML, Fitzpatrick SG, Hellwell T, Kakkar A, Williams MD. Mucosal Melanoma. In: Head and Neck Tumours WHO Classification of Tumours. 5th Edition. International Agency for Research on Cancer, 601-604, 2024.
4. Choisea SI, Liu B, Williams MD. Mucoepidermoid Carcinoma. In: World Health Organization Classification of Tumours: Peadiatric Tumours. International Agency for Research on Cancer, 2023.
5. Williams, MD, El-Naggar, AK. Head and Neck, 129-217, 2021.
6. Williams MD, El-Naggar AK. Pathology and Differential Diagnosis of Anterior Skull Base Tumours. In: Adv Otorhinolaryngol, 13-27, 2020.
7. Williams MD, El-Naggar A. Chapter 3 Head & Neck Pathology. In: Differential Diagnosis in Surgical Pathology. 4th Edition. Elsevier Health Sciences, 2020.
8. Williams MD, Range DE. Thyroid Gland. In: Practical Head and Neck Pathology. Springer, 2020.
9. Williams MD, El-Naggar A. Pathology of Head and Neck Squamous Cell Carcinoma. In: Head and Neck Cancers: Evidence-Based Treatment. Springer, 2018.
10. Kimura N, Capella C, Gill A, Komminoth P, Lam AKY, Tischler AS, Williams MD. Carotid Body Paraganglioma. In: WHO Classification of Head and Neck Tumours. 4th Edition. International Agency for Research on Cancer (IARC), 2017.
11. Williams MD, et al. Condyloma Acuminatum. In: WHO Classification of Head and Neck Tumours. 4th Edition. International Agency for Research on Cancer (IARC), 2017.
12. Chiosea S, Seethala R, Williams MD. Intercalated Duct Hyperplasia. In: WHO Classification of Head and Neck Tumours. 4th Edition. International Agency for Research on Cancer, 2017.
13. Seethala R, Gnepp DR, Skalova A, Slater L, Williams MD. Sclerosing Polycystic Adenosis. In: WHO Classification of Head and Neck Tumours. 4th Edition. International Agency for Research on Cancer, 2017.
14. Muller S, Lippman S, Williams MD. Verruca Vulgaris. In: WHO Classification of Head and Neck Tumours. 4th Edition. International Agency for Research on Cancer (IARC), 2017.
15. El-Naggar AK, Baloch ZW, Eng C, Evans HL, Fagin JA, Fellegara G, Franssila KO, Giuffrida D, Katoh R, Kebebew E, Konda T, Matias-Guiu X, Nikiforov YE, Smallridge R, Sugitani I, Tallini G, Wakely PE, Westra WH, Wick MR, Williams MD. Anaplastic thyroid carcinoma. In: WHO Classification of Tumours of Endocrine Organs. 4th Edition. International Agency for Research on Cancer (IARC), 2017.
16. Williams MD, Speight P, Wenig BM. Mucosal Melanoma-Sinonasal Tract. In: WHO Classification of Head and Neck Tumours. 4th Edition. International Agency for Research on Cancer (IARC), 2017.
17. Tischler AS, de Krijger RR, Gill A, Kawashina A, Kimura N, Komminoth P, Papathomas TG, Thompson LDR, Tissier F, Williams MD, Young WF. Tumours of the adrenal medulla and extra-adrenal paraganglia- Introduction. In: WHO Classification of Tumours of Endocrine Organs. 4th Edition. International Agency for Research on Cancer (IARC), 2017.
18. LiVolsi V, Abdulkader Nallib I, Baloch ZW, Bartolazzi A, Chan JKC, DeLellis RA, El-Naggar AK, Eloy C, Eng C, Fagin JA, Ghossein RA, Gioradano TJ, Konda T, Lloyd RV, Mete O, Nikiforov YE, Nonaka D, Paschke R, Parren A, Rosai J, Sadow P, Schneider AB, Sobrinho Simoes M, Tallini G, Williams MD. Follicular Carcinoma. In: WHO Classification of Tumours of Endocrine Organs. 4th Edition. International Agency for Research on Cancer (IARC), 2017.
19. Williams MD, Di Palma S, Gillison M, Nagao T, Simpson RHW. Carcinosarcoma. In: WHO Classification of Head and Neck Tumours. 4th Edition. International Agency for Research on Cancer (IARC), 2017.
20. Gale N, Hille J, Jordan RC, Nadal A, Williams MD. Dysplasia - Oral Cavity. In: WHO Classification of Head and Neck Tumours. 4th Edition. International Agency for Research on Cancer (IARC), 2017.
21. Kimura N, Capella C, Gill A, Komminoth P, Lam AKY, Tischler AS, Williams MD. Middle Ear Paraganglioma. In: WHO Classification of Head and Neck Tumours. 4th Edition. International Agency for Research on Cancer (IARC), 2017.
22. Williams MD, Speight P, Wenig BM. Mucosal Melanoma-Oral Cavity. In: WHO Classification of Head and Neck Tumours. 4th Edition. International Agency for Research on Cancer (IARC), 2017.
23. Simpson RHW, Chiosea S, Katabi N, Leivo I, Vielh P, Williams MD. Acinic Cell Carcinoma. In: WHO Classification of Head and Neck Tumours. 4th Edition. International Agency for Research on Cancer (IARC), 2017.
24. Tischler AS, de Krijger RR, Gill A, Kawashina A, Kimura N, Komminoth P, Papathomas TG, Thompson LDR, Tissier F, Williams MD, Young WF. Phaeochromocytoma. In: WHO Classification of Tumours of Endocrine Organs. 4th Edition. International Agency for Research on Cancer (IARC), 2017.
25. Nagao T, Licitra L, Leoning T, Vielh P, Williams MD. Salivary Duct Carcinoma. In: WHO Classification of Head and Neck Tumours. 4th Edition. International Agency for Research on Cancer (IARC), 2017.
26. Reibel J, Gale N, Hille J, Hunt JL, Lingen M, Muller S, Sloan P, Tilakaratne WM, Westra WH, Williams MD, Vigneswaran N Fatani HA, Odell EW, Zain RB. Oral potentially malignant disorders and oral epithelial dysplasia. In: WHO Classification of Head and Neck Tumours. 4th Edition. International Agency for Research on Cancer (IARC), 2017.
27. Kimura N, Capella C, Gill A, Komminoth P, Lam AKY, Tischler AS, Williams MD. Laryngeal Paraganglioma. In: WHO Classification of Head and Neck Tumours. 4th Edition. International Agency for Research on Cancer (IARC), 2017.
28. Gale N, Hille J, Jordan RC, Nadal A, Williams MD. Dysplasia-larynx. In: WHO Classification of Head and Neck Tumours. 4th Edition. International Agency for Research on Cancer (IARC), 2017.
29. Kimura N, Capella C, DeLellis RA, Epstein JI, Gill A, Kawashima A, Koch CA, Komminoth P, Lam AKY, Merino MJ, Mete O, Papthomas TG, Sadow P, Thompson LDR, Tishler AS, Williams MD, Young WR. Extra-adrenal paraganglioma. In: WHO Classification of Tumours of Endocrine Organs. 4th Edition. International Agency for Research on Cancer (IARC), 2017.
30. Fonseca, Gnepp, Seethala, Simpson, Williams MD. Basal cell adenocarcinoma. In: WHO Classification of Head and Neck Tumours. 4th Edition. International Agency for Research on Cancer (IARC), 2017.
31. Muller S, Lippman S, Williams MD, et al. Focal Epithelial Hyperplasia. In: WHO Classification of Head and Neck Tumours. 4th Edition. International Agency for Research on Cancer (IARC), 2017.
32. Williams MD, Ihrler S, Seethala R. Carcinoma Ex Pleomorphic Adenoma. In: WHO Classification of Head and Neck Tumours. 4th Edition. International Agency for Research on Cancer (IARC), 2017.
33. Coupland SE, Barnhill R, Conway RM, Damato BE, Esmaeli B, Albert DM, Auw-hadrich C, Chevez-Barrios R, Grossniklaus HE, Heegaard S, Holbach LM, Kivela R, Pavlick AC, Pe'er J, Shields C, Singh AD, Wittekind CW, Williams MD, Prieto VG, Finger PT. Ophthalmic Sites-Conjunctival Melanoma. In: AJCC Cancer Staging Manual. 8th Edition. Springer, 803-811, 2016.
34. Vigneswaran N, Williams MD. Epidemiologic trends in head and neck cancer and aids in diagnosis. In: Oral Maxillofac Surg Clin North Am. 2, 123-41, 2014.
35. Williams MD, El-Naggar AK. Chapter 3 Head and Neck Pathology. In: Differential Diagnosis in Surgical Pathology. Third Edition. Elsevier Health Sciences, 2014.
36. Williams MD, El-Naggar AK. Cancer of the Head & Neck: Pathology. In: Oxford Textbook of Oncology. Third Edition. Oxford University Press, 2013.
37. Ludwig M, Garden AS, Williams MD, Gombos DS. Chapter 15 Managment of Uveal Melanoma. In: M. D. Anderson Solid Tumor Oncology Series: Ophthalmic Oncology. Springer, 201-213, 2011.
38. Williams MD, El-Naggar AK. Chapter 3 Head and Neck Pathology. In: Differential Diagnosis in Surgical Pathology. Second Edition. Saunders, 2009.
39. Williams MD. Pathology of Tumors and Tumor-like Lesions of the Skull Base. In: Comprehensive Management of Skull Base Tumors. First Edition. Informa Heath Care, 43-62, 2008.
40. Perren A, Mete O, Williams MD, Johnson SJ, Juhlin CC. Parathyroid hyperplasia. In: Endocrine and Neuroendocrine Tumours WHO Classification of Tumours. 5th Edition. International Agency for Research on Cancer.
41. Perren A, Mete O, Williams MD, Johnson SJ, Juhlin CC. Parathyroid adenoma. In: Endocrine and Neuroendocrine Tumours WHO Classification of Tumours. 5th Edition. International Agency for Research on Cancer.
42. Perren A, Mete O, Williams MD, Johnson SJ, Juhlin CC. Atypical parathyroid tumour. In: Endocrine and Neuroendocrine Tumours WHO Classification of Tumours. 5th Edition. International Agency for Research on Cancer.
43. Perren A, Mete O, Williams MD, Johnson SJ, Juhlin CC. Parathyroid carcinoma. In: Endocrine and Neuroendocrine Tumours WHO Classification of Tumours. 5th Edition. International Agency for Research on Cancer.
44. Perren A, Mete O, Williams MD, Johnson SJ, Juhlin CC. Parathyroid lipoadenoma. In: Endocrine and Neuroendocrine Tumours WHO Classification of Tumours. 5th Edition. International Agency for Research on Cancer.

Letters to the Editor

1. Qiu L, Weitzman SP, Nastoupil LJ, Williams MD, Medeiros LJ, Vega F. Disseminated ALK-positive histiocytosis with KIF5B-ALK fusion in an adult. Leuk Lymphoma 62: 1234-1238, 2021.
2. Gale N, Hille J, Jordan RC, Nadal A, Williams MD. Regarding Laryngeal precursor lesions: Interrater and intrarater reliability of histopathological assessment. Laryngoscope 129: E91-E92, 2019.
3. Cabanillas ME, Williams MD. Letter to the Editor regarding squamoid pattern of anaplastic thyroid carcinoma, a poorly recognized entity. Head Neck 38: 1290, 2016.